{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:48:57Z","timestamp":1791643737362,"version":"4.3.4"},"reference-count":1085,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.neuropharm.2012.11.015","type":"journal-article","created":{"date-parts":[[2012,12,11]],"date-time":"2012-12-11T09:01:24Z","timestamp":1355216484000},"page":"2-82","source":"Crossref","is-referenced-by-count":206,"special_numbering":"C","title":["An epigenetic framework for neurodevelopmental disorders: From pathogenesis to potential therapy"],"prefix":"10.1016","volume":"68","author":[{"given":"Mark J.","family":"Millan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2012.11.015_bib3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00213-011-2269-5","article-title":"Developmental GABAergic deficit enhances methamphetamine-induced apoptosis","volume":"215","author":"Abekawa","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10048-008-0133-5","article-title":"Heterogeneous dysregulation of microRNAs across the autism spectrum","volume":"9","author":"Abu-Elneel","year":"2008","journal-title":"Neurogenetics"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.pediatrneurol.2012.02.001","article-title":"Cognitive profiles of neurofibromatosis type 1 patients with minor brain malformations","volume":"46","author":"Acosta","year":"2012","journal-title":"Pediatr. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neulet.2007.05.025","article-title":"Preliminary evidence for involvement of the folate gene polymorphism 19bp deletion-DHFR in occurrence of autism","volume":"422","author":"Adams","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neuropharm.2010.05.002","article-title":"Early development al alterations in GABAergic protein expression in fragile X knockout mice","volume":"59","author":"Adusei","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3410\/M4-6","article-title":"Cognitive behaviour therapy for schizophrenia","volume":"4","author":"Addington","year":"2012","journal-title":"F1000 Med. Rep."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib9","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.psyneuen.2012.05.003","article-title":"Stress abnormalities in individuals at risk for psychosis: a review of studies in subjects with familial risk or with \u201cat risk\u201d mental state","volume":"37","author":"Aiello","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib10","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/7854_2010_38","article-title":"Epigenetics of schizophrenia","volume":"4","author":"Akbarian","year":"2010","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib11","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/archpsyc.62.8.829","article-title":"Chromatin alterations associated with down-regulated metabolic gene expression in the prefrontal cortex of subjects with schizophrenia","volume":"62","author":"Akbarian","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib12","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.biopsych.2008.08.015","article-title":"Epigenetic regulation in human brain \u2013 focus on histone lysine methylation","volume":"65","author":"Akbarian","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib13","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.neuron.2004.05.021","article-title":"Chromatin acetylation, memory, and LTP are impaired in CBP+\/\u2212 mice: a model for the cognitive deficit in Rubinstein\u2013Taybi syndrome and its amelioration","volume":"42","author":"Alarc\u00f3n","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib14","series-title":"GeneReviews\u2122 [Internet]","article-title":"Coffin\u2013Lowry syndrome","author":"Alasdair","year":"2002"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2156-12-7","article-title":"Normal social seeking behavior, hyperactivity and reduced exploratory range in a mouse model of Angelman syndrome","volume":"12","author":"Allensworth","year":"2011","journal-title":"BMC Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib16","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/hmg\/ddq519","article-title":"miRNA-132 orchestrates chromatin remodeling and translational control of the circadian clock","volume":"20","author":"Alvarez-Saavedra","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.tins.2007.12.005","article-title":"Neuroanatomy of autism","volume":"31","author":"Amaral","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutation in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.tics.2011.11.016","article-title":"Culture and education: new frontiers in brain plasticity","volume":"16","author":"Ansari","year":"2012","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.brainres.2010.03.008","article-title":"Aberrant RNA processing events in neurological disorders","volume":"1338","author":"Anthony","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib21","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1128\/MCB.00201-08","article-title":"mGluR-dependent long-term depression is associated with increased phosphorylation of S6 and synthesis of elongation factor 1A but remains expressed in S6K-deficient mice","volume":"28","author":"Antion","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib22","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.tcb.2012.02.006","article-title":"Bidirectional crosstalk between endoplasmic reticulum stress and mTOR signaling","volume":"22","author":"Appenzeller-Herzog","year":"2012","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1001\/archgenpsychiatry.2011.150","article-title":"Progressive brain changes in children and adolescents with first-episode psychosis","volume":"69","author":"Arango","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib24","doi-asserted-by":"crossref","first-page":"e21396","DOI":"10.1371\/journal.pone.0021396","article-title":"MiR-34a regulates mouse neural stem cell differentiation","volume":"6","author":"Aranha","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib25","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.molcel.2008.09.003","article-title":"A\u00a0piRNA pathway primed by individual transposons is linked to de novo DNA methylation in mice","volume":"31","author":"Aravin","year":"2008","journal-title":"Mol. Cell."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib26","article-title":"Epigenetics in developmental disorder: ADHD and endophenotypes","volume":"2","author":"Archer","year":"2011","journal-title":"J.\u00a0Genet. Synd. Gene Ther."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib27","doi-asserted-by":"crossref","first-page":"11939","DOI":"10.1073\/pnas.0704057104","article-title":"Structural consequences of disease-causing mutation in the ATRX-DNMT3-DNMT3L (ADD) domain of the chromatin-associated protein ATRX","volume":"104","author":"Argentaro","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.tins.2011.11.007","article-title":"Genetic and cognitive windows into circuit mechanisms of psychiatric disease","volume":"35","author":"Arguello","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib29","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/jnr.22804","article-title":"Epigenetic regulation of self-renewal and fate determination in neural stem cells","volume":"90","author":"Ariff","year":"2012","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib30","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ajhg.2009.04.017","article-title":"Mutation of a gene essential for ribosome biogenesis, EMG1, causes Bowen\u2013Conradi syndrome","volume":"84","author":"Armistead","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib31","doi-asserted-by":"crossref","first-page":"14966","DOI":"10.1523\/JNEUROSCI.2215-12.2012","article-title":"Autism-associated mutations in ProSAP2\/Shank3 impair synaptic transmission and neurexin-neuroligin-mediated transynaptic signaling","volume":"32","author":"Arons","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib32","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nrd3674","article-title":"Epigenetic protein families: a new frontier for drug discovery","volume":"11","author":"Arrowsmith","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib33","doi-asserted-by":"crossref","first-page":"9429","DOI":"10.1093\/nar\/gks716","article-title":"The histone demethylase PHF8 is essential for cytoskeleton dynamics","volume":"40","author":"Arsensio-Juan","year":"2012","journal-title":"Nucleic Acids"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tig.2006.11.008","article-title":"Another role for RNA: a messenger across generations","volume":"23","author":"Ashe","year":"2007","journal-title":"Trends Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib35","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.febslet.2010.10.042","article-title":"The role of deubiquitinating enzymes in chromatin regulation","volume":"585","author":"Atanassov","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib36","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nature10658","article-title":"Mutations causing syndromic autism define an axis of synaptic pathophysiology","volume":"480","author":"Auerbach","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib37","doi-asserted-by":"crossref","first-page":"32282","DOI":"10.1074\/jbc.M104661200","article-title":"Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin","volume":"276","author":"Bachman","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib38","first-page":"e4132","article-title":"Generation, purification, and characterization of cell-invasive DISC1 protein species","volume":"66","author":"Bader","year":"2012","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1399-0004.2009.01331.x","article-title":"A\u00a0novel nonsense mutation in CUL4B gene in three brothers with X-linked mental retardation syndrome","volume":"77","author":"Badura-Stronka","year":"2010","journal-title":"Clin. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib40","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000331333","article-title":"CDKL5-related disorders: from clinical description to molecular genetics","volume":"2","author":"Bahi-Buisson","year":"2012","journal-title":"Mol. Syndromol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib41","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nature10531","article-title":"Somatic retransposition alters the genetic landscape of the human brain","volume":"479","author":"Baillie","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mrfmmm.2008.07.004","article-title":"PHD fingers in human diseases: disorders arising from misinterpreting epigenetic marks","volume":"647","author":"Baker","year":"2008","journal-title":"Mutat. Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib43","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.biopsych.2010.05.028","article-title":"Early life programming and neurodevelopmental disorders","volume":"68","author":"Bale","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib44","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bbr.2009.11.008","article-title":"Reduced exploration, increased anxiety, and altered social behavior: autistic-like features of euchromatin histone methyltransferase 1 heterozygous knockout mice","volume":"208","author":"Balemans","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib45","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nn.2275","article-title":"Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology","volume":"12","author":"Ballas","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib46","doi-asserted-by":"crossref","first-page":"14108","DOI":"10.1073\/pnas.0804650106","article-title":"Changing numbers of neuronal and non-neuronal cells underlie postnatal brain growth in the rat","volume":"106","author":"Bandeira","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib47","doi-asserted-by":"crossref","first-page":"15996","DOI":"10.1073\/pnas.1019012108","article-title":"Neurofibromatosis-1 regulates mTOR-mediated astrocyte growth and glioma formation in a TSC\/Rheb-independent manner","volume":"108","author":"Banerjee","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib48","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.cell.2011.03.052","article-title":"Enhanced polyubiquitination of Shank3 and NMDA receptor in a mouse model of autism","volume":"145","author":"Bangash","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib49","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1523\/JNEUROSCI.5196-05.2006","article-title":"Regulation of eukaryotic initiation factor 4E by converging signaling pathways during metabotropic glutamate receptor-dependent long-term depression","volume":"26","author":"Banko","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib50","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/B978-0-444-53630-3.00011-7","article-title":"Empathizing, systemizing, and the extreme male brain theory of autism","volume":"186","author":"Baron-Cohen","year":"2010","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib51","doi-asserted-by":"crossref","first-page":"16716","DOI":"10.1074\/jbc.M110.180844","article-title":"DiGeorge critical region 8 (DGCR8) is a double-cysteine-ligated heme protein","volume":"286","author":"Barr","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib52","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/npp.2011.61","article-title":"Hippocampal focal knockout of CBP affects specific histone modifications, long-term potentiation, and long-term memory","volume":"36","author":"Barrett","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib53","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib54","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/jmg.2006.046698","article-title":"Genetic heterogeneity in Rubinstein\u2013Taybi syndrome: delineation of the phenotype of the first patients carrying mutations in EP300","volume":"44","author":"Bartholdi","year":"2007","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib55","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuron.2008.10.004","article-title":"Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function","volume":"60","author":"Bassel","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib56","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1093\/hmg\/ddn307","article-title":"Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome","volume":"17","author":"Bassett","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib57","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.nbd.2012.04.002","article-title":"Ampakines promote spine actin polymerization, long-term potentiation, and learning in a mouse model of Angelman syndrome","volume":"47","author":"Baudry","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib58","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.gene.2007.10.037","article-title":"snoTARGET shows that human orphan snoRNA targets locate close to alternative splice junctions","volume":"408","author":"Bazeley","year":"2008","journal-title":"Gene"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib59","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1371\/journal.pbio.1000016","article-title":"A\u00a0novel function for fragile X mental retardation protein in translational activation","volume":"7","author":"Bechara","year":"2009","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib60","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1476-4598-9-134","article-title":"Microprocessor of microRNAs: regulation and potential for therapeutic intervention","volume":"9","author":"Beezhold","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib61","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.neuron.2005.07.007","article-title":"Modulation of synaptic plasticity and memory by Reelin involves differential splicing of the lipoprotein receptor Apoer2","volume":"18","author":"Beffert","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib62","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nn.2447","article-title":"Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes","volume":"13","author":"Belforte","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib63","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1523\/JNEUROSCI.1547-09.2009","article-title":"The Down syndrome critical region is sufficient in the mouse model to confer behavioral neurophysiological, and synaptic phenotypes characteristic of Down syndrome","volume":"29","author":"Belichenko","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib64","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/cne.21433","article-title":"Synaptic and cognitive abnormalities in mouse models of Down syndrome: exploring genotype-phenotype relationship","volume":"504","author":"Belichenko","year":"2007","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib65","doi-asserted-by":"crossref","first-page":"10164","DOI":"10.1073\/pnas.0703806104","article-title":"Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars","volume":"104","author":"Benes","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib66","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jneumeth.2011.07.009","article-title":"A\u00a0non-invasive method to isolate the neuronal linage from the nasal epithelium from schizophrenic and bipolar diseases","volume":"201","author":"Benitez-King","year":"2011","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib67","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.tins.2010.02.001","article-title":"CREB's control of intrinsic and synaptic plasticity: implications for CREB-dependent models","volume":"33","author":"Benito","year":"2010","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib68","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.pneurobio.2011.08.003","article-title":"Schizophrenia: susceptibility genes, dendritic-spine pathology and gray matter loss","volume":"95","author":"Bennett","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib69","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1073\/pnas.0906831106","article-title":"Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma","volume":"106","author":"Berdasco","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib70","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nature05915","article-title":"The complex language of chromatin regulation during transcription","volume":"447","author":"Berger","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib71","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1101\/sqb.2010.75.044","article-title":"Cell signaling and transcriptional regulation via histone phosphorylation","volume":"75","author":"Berger","year":"2010","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib72","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1101\/gad.1787609","article-title":"An operational definition of epigenetics","volume":"23","author":"Berger","year":"2009","journal-title":"Genes Dev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib73","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/jmg.2010.087106","article-title":"CHD7 mutations and CHARGE syndrome: the clinical implications of an expanding phenotype","volume":"48","author":"Bergman","year":"2011","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib74","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/humu.22106","article-title":"A\u00a0novel classification system to predict the pathogenic effects of CHD7 missense variants in CHARGE syndrome","volume":"33","author":"Bergman","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib75","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1523\/JNEUROSCI.1039-08.2008","article-title":"Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol","volume":"28","author":"Bertran-Gonzalez","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib76","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1139\/o11-038","article-title":"ATRX in chromatin assembly and genome architecture during development and disease","volume":"89","author":"Berube","year":"2011","journal-title":"Biochem. Cell. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib77","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/sj.ejhg.5201943","article-title":"Patient mutations alter ATRX targeting to PML nuclear bodies","volume":"16","author":"Berube","year":"2008","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib78","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/hmg\/11.3.253","article-title":"Neurodevelopmental defects resulting from ATRX overexpression in transgenic mice","volume":"11","author":"B\u00e9rub\u00e9","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib79","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1172\/JCI200522329","article-title":"The chromatin-remodeling protein ATRX is critical for neuronal survival during corticogenesis","volume":"115","author":"B\u00e9rub\u00e9","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib80","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.drudis.2010.10.006","article-title":"Epigenetic therapies for non-oncology indications","volume":"15","author":"Best","year":"2010","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib81","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.brainres.2010.11.078","article-title":"Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting","volume":"1380","author":"Betancur","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib82","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.nbd.2011.12.029","article-title":"MicroRNA dysregulation in schizophrenia","volume":"46","author":"Beveridge","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib83","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/mp.2009.84","article-title":"Schizophrenia is associated with an increase in cortical microRNA biogenesis","volume":"15","author":"Beveridge","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib84","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1093\/hmg\/ddn005","article-title":"Dysregulation of miRNA 181b in the temporal cortex in schizophrenia","volume":"17","author":"Beveridge","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib85","doi-asserted-by":"crossref","first-page":"e1000017","DOI":"10.1371\/journal.pgen.1000017","article-title":"SIRT1 inhibition alleviates gene silencing in fragile X mental retardation syndrome","volume":"4","author":"Biacsi","year":"2008","journal-title":"PLoS Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib86","doi-asserted-by":"crossref","first-page":"6827","DOI":"10.1021\/ja101557k","article-title":"Biochemical, structural, and biological evaluation of tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and LSD2","volume":"132","author":"Binda","year":"2010","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib87","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature05913","article-title":"Perceptions of epigenetics","volume":"447","author":"Bird","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib88","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.nlm.2008.11.003","article-title":"Learning under stress: a role for the neural cell adhesion molecule NCAM","volume":"91","author":"Bisaz","year":"2009","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib89","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1093\/hmg\/ddm225","article-title":"Inactivation of the mouse Magel2 gene results in growth abnormalities similar to Prader\u2013Willi syndrome","volume":"16","author":"Bishof","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib90","doi-asserted-by":"crossref","first-page":"e15112","DOI":"10.1371\/journal.pone.0015112","article-title":"Which neurodevelopmental disorders get researched and why?","volume":"5","author":"Bishop","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib91","series-title":"Rutter's Child and Adolescent Psychiatry","first-page":"32","article-title":"Neurodevelopmental disorders: conceptual issues","author":"Bishop","year":"2004"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib92","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1651-2227.2011.02150.x","article-title":"Klinefelter syndrome as a window on the aetiology of language and communication impairments in children: the neuroligin-neurexin hypothesis","volume":"100","author":"Bishop","year":"2011","journal-title":"Acta. Paediatr."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib93","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/schbul\/sbq035","article-title":"TCF4, schizophrenia, and Pitt\u2013Hopkins syndrome","volume":"36","author":"Blake","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib94","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1258\/jrsm.2011.110221","article-title":"Development of the social brain in adolescence","volume":"105","author":"Blakemore","year":"2012","journal-title":"J.\u00a0R. Soc. Med."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib95","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0140-6736(02)07340-3","article-title":"Psychotic illness in people with Prader Willi syndrome due to chromosome 15 maternal uniparental disomy","volume":"359","author":"Boer","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib96","article-title":"Epigenetic inheritance of disease and disease risk","author":"Bohacek","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/epi.7.1.18688","article-title":"Current status and future prospects for epigenetic psychopharmacology","volume":"7","author":"Boks","year":"2012","journal-title":"Epigenetics"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib98","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrd3823","article-title":"The spliceosome as a target of novel antitumour drugs","volume":"11","author":"Bonnal","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib99","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/ng.708","article-title":"Targets and dynamics of promoter DNA methylation during early mouse development","volume":"42","author":"Borgel","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib100","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.1093\/nar\/gks321","article-title":"The SNORD115 (H\/MBII-52) and SNORD116 (H\/MBH-85) gene clusters at the imprinted Prader\u2013Willi locus generate canomical box C\/D snoRNAs","volume":"40","author":"Bortolin-Cavaill\u00e9","year":"2012","journal-title":"J. Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib101","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.pneurobio.2010.06.010","article-title":"Adolescent brain maturation, the endogenous cannibinoid system and the neurobiology of cannabis-induced schizophrenia","volume":"92","author":"Bossong","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib102","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrn1428","article-title":"Immune signalling in neural development, synaptic plasticity and disease","volume":"5","author":"Boulanger","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib103","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.conb.2009.06.003","article-title":"A\u00a0synaptic trek to autism","volume":"19","author":"Bourgeron","year":"2009","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib104","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1101\/sqb.2007.72.020","article-title":"The possible interplay of synaptic and clock genes in autism spectrum disorders","volume":"72","author":"Bourgeron","year":"2007","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib105","doi-asserted-by":"crossref","first-page":"10518","DOI":"10.1073\/pnas.1834280100","article-title":"A\u00a0mouse model of Rubinstein\u2013Taybi syndrome defective long-term memory is ameliorated by inhibitors of phosphodiesterase 4","volume":"100","author":"Bourtchouladze","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"8","key":"10.1016\/j.neuropharm.2012.11.015_bib106","doi-asserted-by":"crossref","first-page":"e42422","DOI":"10.1371\/journal.pone.0042422","article-title":"Haploinsufficiency of Cyfip 1 produces fragile x-like phenotypes in mice","volume":"7","author":"Bozdagi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib107","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/2040-2392-1-15","article-title":"Haploinsufficiency of the autism-associated shank3 gene leads to deficits in synaptic function, social interaction, and social communication","volume":"1","author":"Bozdagi","year":"2010","journal-title":"Mol. Autism"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib108","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nrn2150","article-title":"Dendritic mRNA: transport, translation and function","volume":"8","author":"Bramham","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib109","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00221-009-1959-2","article-title":"The Arc of synaptic memory","volume":"200","author":"Bramham","year":"2010","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib110","doi-asserted-by":"crossref","first-page":"11444","DOI":"10.1523\/JNEUROSCI.1711-05.2005","article-title":"Parsing molecular and behavioral effects of cocaine in mitogen- and stress-activated protein kinase-1-deficient mice","volume":"25","author":"Brami-Cherrier","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib111","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrg3080","article-title":"Uncovering the role of 5-hydroxymethylcytosine in the epigenome","volume":"13","author":"Branco","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib112","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1007\/s00018-011-0762-y","article-title":"Biology and applications of small nucleolar RNAs","volume":"68","author":"Bratkovic","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1072","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1177\/0269881111405366","article-title":"Specific targeting of the GABA-A receptor a5 subtype by a selective inverse agonist restores cognitive deficits in down syndrome mice","volume":"25","author":"Braudeau","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1073","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1128\/MCB.05289-11","article-title":"Analysis of human syndromes with disordered chromatin reveals the impact of heterochromatin on the efficacy of ATM-dependent G2\/M checkpoint arrest","volume":"31","author":"Brunton","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib113","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00109-010-0704-4","article-title":"Read through of nonsense mutation in Rett syndrome: evaluation of novel amino glycosides and generation of a new mouse model","volume":"89","author":"Brendel","year":"2011","journal-title":"J.\u00a0Mol. Med."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib114","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1002\/stem.762","article-title":"Concise review: the promise of human induced pluripotent stem cell-based studies of schizophrenia","volume":"29","author":"Brennand","year":"2011","journal-title":"Stem Cells"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib115","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1126\/science.1165171","article-title":"An epigenetic role for maternally inherited piRNAs in transposon silencing","volume":"322","author":"Brennecke","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib116","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.nbd.2011.07.008","article-title":"Impairment of cognitive performance after reelin knockdown in the medial prefrontal cortex of pubertal or adult rats","volume":"44","author":"Brosda","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib117","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pneurobio.2010.09.003","article-title":"The environment and susceptibility to schizophrenia","volume":"93","author":"Brown","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib118","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/archpsyc.64.1.31","article-title":"Elevated prenatal homocysteine levels as a risk factor for schizophrenia","volume":"64","author":"Brown","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib119","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nsmb.1821","article-title":"Repressive and active histone methylation mark distinct promoters in human and mouse spermatozoa","volume":"17","author":"Brykczynska","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.biopsych.2010.03.015","article-title":"Cognitive and sensorimotor gating impairments in transgenic mice overexpressing the schizophrenia gene tcf4 in the brain","volume":"68","author":"Brzozka","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib121","first-page":"1","article-title":"Enhancers as information integration hubs in development: lessons from genomics","volume":"944","author":"Buecker","year":"2012","journal-title":"Trends Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib122","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ajmg.c.30273","article-title":"Prader\u2013Willi and Angelman syndrome","volume":"154C","author":"Buiting","year":"2010","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.neuro.29.051605.112800","article-title":"Adaptive roles of programmed cell death during nervous system development","volume":"29","author":"Buss","year":"2006","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib124","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1755-8794-1-50","article-title":"Multiplex ligation-dependent proven amplification for genetic screening in autism spectrum disorders: efficient identification of known microduplications and identification of a novel microduplication in ASMT","volume":"1","author":"Cai","year":"2008","journal-title":"BMC Med. Genomics"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1074","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.cell.2012.10.037","article-title":"Site-specific silencing of regulatory elements as a mechanism of X inactivation","volume":"151","author":"Calabrese","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib125","first-page":"498","article-title":"Reversibility of functional deficits in experimental models of Rett syndrome","volume":"38","author":"Calfa","year":"2011","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib126","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fonc.2012.00026","article-title":"Histone ubiquitination and deubiquitination in transcription, DNA damage response, and cancer","volume":"2","author":"Cao","year":"2012","journal-title":"Front. Oncol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib127","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1017\/S0954422411000102","article-title":"Epigenetic mechanisms elicited by nutrition in early life","volume":"224","author":"Canani","year":"2011","journal-title":"Nutr. Res. Rev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib128","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1136\/jmg.37.10.746","article-title":"ATR-X mutations cause impaired nuclear location and altered DNA binding properties of the XNP\/ATR-X protein","volume":"37","author":"Cardoso","year":"2000","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib129","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/hmg\/7.4.679","article-title":"Specific interaction between the XNP\/ATR-X gene product and the SET domain of the human EZH2 protein","volume":"7","author":"Cardoso","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib130","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.drudis.2011.05.004","article-title":"DNA demethylases: a new epigenetic frontier in drug discovery","volume":"16","author":"Carey","year":"2011","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib131","doi-asserted-by":"crossref","first-page":"R852","DOI":"10.1016\/S0960-9822(02)01352-0","article-title":"RNA interference: the fragile X syndrome connection","volume":"12","author":"Carthew","year":"2002","journal-title":"Curr. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib132","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1124\/mol.106.022301","article-title":"Fluoxetine and cocaine induce the epigenetic factors MeCP2 and MBD1 in adult rat brain","volume":"70","author":"Cassel","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib133","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/gim.0b013e31822bead0","article-title":"Prader\u2013Willi syndrome","volume":"14","author":"Cassidy","year":"2012","journal-title":"Genet. Med."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib134","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s11064-010-0359-0","article-title":"Neurofibromin and amyloid precursor protein expression in dopamine D3 receptor knock-out mice brains","volume":"36","author":"Castorina","year":"2010","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib135","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0166-2236(95)93933-O","article-title":"Numbers, time and neocortical neurogenesis: a general developmental and evolutionary model","volume":"18","author":"Caviness","year":"1995","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib136","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrg2540","article-title":"Linking DNA methylation and histone modification: patterns and paradigms","volume":"10","author":"Cedar","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib137","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.biopsych.2007.09.008","article-title":"Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome","volume":"63","author":"Centonze","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib138","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1002\/ajmg.a.35486","article-title":"Immunodeficiency, centromeric instability, facial anomalies (ICF) syndrome, due to ZBTB24 mutations, presenting with large cerebral cyst","volume":"158A","author":"Cerbone","year":"2012","journal-title":"Am. J. Med. Genet. A."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib139","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1186\/1471-2164-11-448","article-title":"Brain transcriptional stability upon prion protein-encoding gene invalidation in zygotic or adult mouse","volume":"11","author":"Chadi","year":"2010","journal-title":"BMC Genomics"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib140","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1126\/science.1153252","article-title":"MeCP2, a key contributor to neurological disease, activates and represses transcription","volume":"320","author":"Chahrour","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib141","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1111\/j.1349-7006.2010.01616.x","article-title":"MicroRNA-10b regulates tumorigenesis in neurofibromatosis type 1","volume":"101","author":"Chai","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1075","doi-asserted-by":"crossref","first-page":"281","DOI":"10.31887\/DCNS.2012.14.3\/pchaste","article-title":"Autism risk factors: genes, environment, and gene-environment interactions","volume":"14","author":"Chaste","year":"2012","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib142","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.neubiorev.2007.10.009","article-title":"Epigenetic mechanisms mediating the long-term effects of maternal care on development","volume":"33","author":"Champagne","year":"2009","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib143","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.cell.2007.02.007","article-title":"Paramutation: from maize to mice","volume":"128","author":"Chandler","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib144","doi-asserted-by":"crossref","first-page":"460","DOI":"10.4161\/epi.5.6.12314","article-title":"Histone H2B ubiquitination and beyond: regulation of nucleosome stability, chromatin dynamics and the trans-histone H3 methylation","volume":"5","author":"Chandrasekharan","year":"2010","journal-title":"Epigenetics"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib145","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nsmb.1560","article-title":"Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294","volume":"16","author":"Chang","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib146","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nature09582","article-title":"Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes","volume":"468","author":"Chao","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib147","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.nbd.2009.05.001","article-title":"Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations","volume":"35","author":"Chapleau","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib148","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/pr.2011.40","article-title":"Postnatal infection is associated with widespread abnormalities of brain development in premature newborns","volume":"71","author":"Chau","year":"2012","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib149","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev.biochem.77.062706.153223","article-title":"The biology of chromatin remodeling complexes","volume":"78","author":"Clapier","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib150","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/jmg.40.2.87","article-title":"Angelman syndrome: a review of the clinical and genetic aspects","volume":"40","author":"Clayton-Smith","year":"2003","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib151","doi-asserted-by":"crossref","first-page":"8824","DOI":"10.1073\/pnas.1001702107","article-title":"Developmental regulation and individual differences of neuronal H3K4me3 epigenomes in the prefrontal cortex","volume":"107","author":"Cheung","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib152","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1093\/hmg\/8.12.2317","article-title":"Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMRI1 gene","volume":"8","author":"Chiurazzi","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib153","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/sj.mp.4002106","article-title":"The DISC locus in psychiatric illness","volume":"13","author":"Chubb","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib154","doi-asserted-by":"crossref","first-page":"12732","DOI":"10.1523\/JNEUROSCI.2522-07.2007","article-title":"The nuclear kinase mitogen- and stress-activated protein kinase 1 regulates hippocampal chromatin remodeling in memory formation","volume":"27","author":"Chwang","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib155","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1101\/lm.152906","article-title":"ERK\/MAPK regulates hippocampal histone phosphorylation following contextual fear conditioning","volume":"13","author":"Chwang","year":"2006","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib156","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1093\/nar\/gks031","article-title":"DNMT1 modulation gene expression without its catalytic activity partially through its interactions with histone-modifying enzymes","volume":"40","author":"Clements","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib157","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuron.2011.08.022","article-title":"Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function","volume":"72","author":"Cohen","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib158","first-page":"209","article-title":"The administration of methionine to chronic schizophrenic patients: a review of ten studies","volume":"8","author":"Cohen","year":"1974","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib159","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/00001756-200307180-00019","article-title":"Cellular prion protein ablation impairs behavior as a function of age","volume":"14","author":"Coitinho","year":"2003","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib160","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0006-8993(97)00087-5","article-title":"Mossy fibre reorganization in the hippocampus of prion protein null mice","volume":"755","author":"Colling","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib161","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/370295a0","article-title":"Prion protein is necessary for normal synaptic function","volume":"370","author":"Collinge","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib162","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4161\/epi.3.2.5938","article-title":"DNA methylation changes in schizophrenia and bipolar disorder","volume":"3","author":"Connor","year":"2008","journal-title":"Epigenetics"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib163","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1101\/lm.2043811","article-title":"Fragile X mental retardation protein regulates heterosynaptic plasticity in the hippocampus","volume":"18","author":"Connor","year":"2011","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib164","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nature08516","article-title":"Origins and functional impact of copy number variation in the human genome","volume":"464","author":"Conrad","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2010.01.003","article-title":"Communication breaks-down: from neurodevelopment defects to cognitive disabilities in Down syndrome","volume":"91","author":"Contestabile","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1076","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1177\/0883073811420296","article-title":"Phosphatase and tensin homolog (PTEN) gene mutations and autism: literature review and a case report of a patient with Cowden syndrome, autistic disorder, and epilepsy","volume":"27","author":"Conti","year":"2012","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib166","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/nrd2974","article-title":"Protein methyltransferases as a target class for drug discovery","volume":"8","author":"Copeland","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib167","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mrrev.2009.06.001","article-title":"The complex relationship between folate\/homocysteine metabolism and risk of Down syndrome","volume":"682","author":"Coppede","year":"2009","journal-title":"Mutat. Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib168","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.schres.2011.11.035","article-title":"HPA axis function and symptoms in adolescents at clinical high risk for schizophrenia","volume":"135","author":"Corcoran","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib169","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nature711","article-title":"Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1","volume":"415","author":"Costa","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib170","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.neuron.2007.10.016","article-title":"Mapping early brain development in autism","volume":"56","author":"Courchesne","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib171","doi-asserted-by":"crossref","first-page":"11451","DOI":"10.1523\/JNEUROSCI.1758-09.2009","article-title":"Antidepressant actions of histone deacetylase inhibitors","volume":"29","author":"Covington","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib172","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.neuron.2011.06.007","article-title":"A\u00a0role for repressive histone methylation in cocaine-induced vulnerability to stress","volume":"71","author":"Covington","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib173","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-61779-504-6_1","article-title":"Mitochondrial DNA mutations: an overview of clinical and molecular aspects","volume":"837","author":"Craigen","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib174","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/171639","article-title":"Molecular and cellular alterations in Down syndrome: toward the identification of targets for therapeutics","volume":"2012","author":"Cr\u00e9au","year":"2012","journal-title":"Neural Plast."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib175","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1469-185X.2008.00050.x","article-title":"Genomic imprinting in the development and evolution of psychotic spectrum conditions","volume":"83","author":"Crespi","year":"2008","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib176","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1017\/S0140525X08004214","article-title":"Psychosis and autism as diametrical disorders of the social brain","volume":"31","author":"Crespi","year":"2008","journal-title":"Behav. Brain Sci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib177","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1073\/pnas.0906080106","article-title":"Comparative genomics of autism and schizophrenia","volume":"107","author":"Crespi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib178","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.nbd.2005.01.001","article-title":"Mice devoid of prion protein have cognitive deficits that are rescued by reconstitution of PrP in neurons","volume":"19","author":"Criado","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib179","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3945\/an.111.000992","article-title":"Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate's role","volume":"3","author":"Crider","year":"2012","journal-title":"Am. Soc. Nutr. Adv. Nutr."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib180","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1098\/rspb.2011.2646","article-title":"The penetrance of an epigenetic trait in mice is progressively yet reversibly increased by selection and environment","volume":"279","author":"Cropley","year":"2012","journal-title":"Proc. R. Soc. B."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib181","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1242\/jcs.00804","article-title":"Chromatin remodeling and neuronal response: multiple signaling pathways induce specific histone H3 modifications and early gene expression in hippocampal neurons","volume":"116","author":"Crosio","year":"2003","journal-title":"J.\u00a0Cell. Sci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib182","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tics.2006.12.001","article-title":"Teachers in the wild","volume":"11","author":"Csibra","year":"2007","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib183","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2217\/bmm.10.68","article-title":"Chromatin conformation signatures: ideal human disease biomarkers?","volume":"4","author":"Crutchley","year":"2010","journal-title":"Biomark. Med."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib184","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1101\/gr.082800.108","article-title":"Global analysis of the insulator binding protein CTCF in chromatin barrier regions reveals demarcation of active and repressive domains","volume":"19","author":"Cuddapah","year":"2009","journal-title":"Genome Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib185","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cell.2008.09.060","article-title":"Neurofibromin regulation of ERK signaling modulates GABA release and learning","volume":"135","author":"Cui","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib186","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1021\/ja909996p","article-title":"Comparative analysis of small molecules and histone substrate analogues as LSD1 lysine demethylase inhibitors","volume":"132","author":"Culhane","year":"2010","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib187","unstructured":"Cummings, E., Donohoe, G., Hargreaves, A., Moore, S., Fahey, C., Dinan, T.G., McDonald, C., O'Callaghan, E., Waddington, J.L., Murphy, K.C., Morris, D.W., Gill, M., Corvin, A. Mood congruent psychotic symptoms and specific cognitive deficits in carriers of the novel schizophrenia risk variant at MIR-137. Neurosci. Lett., in press."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib188","first-page":"1","article-title":"A\u00a0simple role for BDNF in learning and memory?","volume":"3","author":"Cunha","year":"2010","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib189","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis","volume":"372","author":"Curatolo","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib190","doi-asserted-by":"crossref","first-page":"e27221","DOI":"10.1371\/journal.pone.0027221","article-title":"Adeno-associated virus-mediated rescue of the cognitive defects in a mouse model for Angelman syndrome","volume":"6","author":"Daily","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib191","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.gde.2012.05.001","article-title":"A fox stops the Wnt: implications for forebrain development and diseases","volume":"22","author":"Danesin","year":"2012","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib192","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cell.2011.06.013","article-title":"FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism","volume":"146","author":"Darnell","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib193","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature07861","article-title":"CBP\/p300-mediated acetylation of histone H3 on lysine 56","volume":"459","author":"Das","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib194","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1242\/dmm.007716","article-title":"The use of mouse models to understand and improve cognitive deficits in Down syndrome","volume":"4","author":"Das","year":"2011","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib195","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1158\/0008-5472.CAN-04-4058","article-title":"Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors","volume":"65","author":"Dasgupta","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib196","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.semcancer.2007.04.001","article-title":"Dietary histone deacetylase inhibitors: from cells to mice to man","volume":"17","author":"Dashwood","year":"2007","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib197","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1523\/JNEUROSCI.5841-11.2012","article-title":"Isoform-specific toxicity of Mecp2 in postmitotic neurons: suppression of neurotoxicity by FoxG1","volume":"32","author":"Dastidar","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib198","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrg2968","article-title":"Current prospects for RNA interference-based therapies","volume":"12","author":"Davidson","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib199","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","article-title":"Cancer epigenetics: from mechanism to therapy","volume":"150","author":"Dawson","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib200","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/npp.2011.85","article-title":"Epigenetic treatments for cognitive impairments","volume":"37","author":"Day","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib201","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrg3188","article-title":"Understanding transgenerational epigenetic inheritance via the gametes in mammals","volume":"13","author":"Daxinger","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib202","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/YCO.0b013e328323d52e","article-title":"Recent advances in postmortem pathology and neurochemistry in schizophrenia","volume":"22","author":"Dean","year":"2009","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib203","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1101\/gad.2037511","article-title":"CpG islands and the regulation of transcripts","volume":"15","author":"Deaton","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib204","unstructured":"Debnath, M., Cannon, D.M., Venkatasubramanian, G. Variation in the major histocompatibility complex [MHC] gene family in schizophrenia: associations and functional implications. Prog. Neuropsychopharmacol. Biol. Psychiatry, in press."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib205","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nn.2614","article-title":"MeCP2 in the nucleus accumbens contributes to neural and behavioral responses to psychostimulants","volume":"13","author":"Deng","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib206","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2009.01.025","article-title":"Screening for genomic rearrangements and methylation abnormalities of the 15q11 q13 region in autism spectrum disorders","volume":"5","author":"Depienne","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib207","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature10907","article-title":"Wild-type microglia arrest pathology in a mouse model of Rett syndrome","volume":"484","author":"Derecki","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib208","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mcn.2009.09.013","article-title":"Fragile X mental retardation protein control of neuronal mRNA metabolism: insights into mRNA stability","volume":"43","author":"De Rubeis","year":"2010","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib209","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11689-011-9087-2","article-title":"Regulation of molecular pathways in the Fragile X syndrome: insights into autism spectrum disorders","volume":"3","author":"De Rubeis","year":"2011","journal-title":"J.\u00a0Neurodev. Disord."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib210","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/978-3-7091-0932-8_23","article-title":"Molecular and cellular aspects of mental retardation in the Fragile X syndrome: from gene mutation\/s to spine dysmorphogenesis","volume":"970","author":"De Rubeis","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"issue":"6","key":"10.1016\/j.neuropharm.2012.11.015_bib211","doi-asserted-by":"crossref","first-page":"e21685","DOI":"10.1371\/journal.pone.0021685","article-title":"Proton magnetic spectroscopy in 22q11 deletion syndrome","volume":"6","author":"De Silva Alves","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib212","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neuron.2009.09.002","article-title":"Cytokines and CNS development","volume":"64","author":"Deverman","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib213","first-page":"275","article-title":"Targeted treatments for cognitive and neurodevelopmental disorders in tuberous sclerosis complex","volume":"7","author":"De Vries","year":"2010","journal-title":"J.\u00a0Am. Soc. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib214","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.nbd.2008.04.002","article-title":"Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice","volume":"31","author":"De Vrij","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib215","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/ajmg.a.33253","article-title":"22q13.3 deletion syndrome: clinical and molecular analysis using array CGH","volume":"152A","author":"Dhar","year":"2010","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib216","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/bies.201100042","article-title":"It takes guts to grow a brain: increasing evidence of the important role of the intestinal microflora in neuro- and immune-modulatory functions during development and adulthood","volume":"33","author":"Diamond","year":"2011","journal-title":"Bioessays"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib217","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/j.1460-9568.2011.07658.x","article-title":"In sickness and in health: the role of methyl-CpG binding protein 2 in the central nervous system","volume":"33","author":"Diaz de Leon-Guerrero","year":"2011","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib218","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1073\/pnas.1010529108","article-title":"Normal gut microbiota modulates brain development and behavior","volume":"108","author":"Diaz Heijtz","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1077","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nrn3314","article-title":"Down syndrome: the brain in trisomic mode","volume":"13","author":"Dierssen","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib219","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.biopsych.2011.05.005","article-title":"Paternal transmission of stress-induced pathologies","volume":"70","author":"Dietz","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib220","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.febslet.2010.11.010","article-title":"Histone arginine methylation","volume":"585","author":"Di Lorenzo","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib221","doi-asserted-by":"crossref","first-page":"e1709","DOI":"10.1371\/journal.pone.0001709","article-title":"SnoRNA Snord116 (Pwerl\/MBII-85) deletion causes growth deficiency and hyperphagia in mice","volume":"3","author":"Ding","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib222","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1021\/cb300135h","article-title":"Small molecule that targets r(CGG)(exp) and improves defects in Fragile X-associated tremor ataxia syndrome","volume":"19","author":"Disney","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib223","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1093\/hmg\/ddp137","article-title":"Loss of the imprinted snoRNA mbii-52 leads to increased 5HTR2C pre-RNA editing and altered 5-HT2CR-mediated behavior","volume":"18","author":"Doe","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib224","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1399-0004.2011.01773.x","article-title":"Recent genomic advances in schizophrenia","volume":"81","author":"Doherty","year":"2012","journal-title":"Clin. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib225","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pharmthera.2010.02.008","article-title":"Mechanism-based approaches to treating fragile X","volume":"127","author":"D\u00f6len","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib226","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2202-7-22","article-title":"Cognitive dysfunction in NF1 knock-out mice may result from altered vesicular trafficking of APP\/DRD3 complex","volume":"7","author":"Donarum","year":"2006","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib227","doi-asserted-by":"crossref","first-page":"12578","DOI":"10.1073\/pnas.0505394102","article-title":"Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia","volume":"102","author":"Dong","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib228","doi-asserted-by":"crossref","first-page":"730","DOI":"10.4161\/epi.5.8.13053","article-title":"Valproate induces DNA demethylation in nuclear extracts from adult mouse brain","volume":"5","author":"Dong","year":"2010","journal-title":"Epigenetics"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib229","unstructured":"Dong, E., Gavin, E.P., Chen, Y., Davis, J. Up-regulation of TET1 and down-regulation of APOBEC3A and APOBEC3C in the parietal cortex of psychotic patients. Transl. Psychiatry, in press."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib230","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.1073\/pnas.0700529104","article-title":"Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters","volume":"104","author":"Dong","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib231","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1086\/345647","article-title":"NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes","volume":"72","author":"Douglas","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib232","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.bmcl.2010.02.069","article-title":"Towards the development of potent and selective bisubstrate inhibitors of protein arginine methyltransferases","volume":"20","author":"Dowden","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib233","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/cne.21264","article-title":"Differential distribution of the MeCP2 splice variants in the postnatal mouse brain","volume":"501","author":"Dragich","year":"2007","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib234","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ijdevneu.2010.09.007","article-title":"The22q11.2 microdeletion: fifteen years of insights into the genetic and neural complexity of psychiatric disorders","volume":"29","author":"Drew","year":"2011","journal-title":"Int. Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib235","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1093\/hmg\/ddr262","article-title":"A\u00a0new deletion refines the boundaries of the murine Prader\u2013Willi syndrome imprinting center","volume":"20","author":"Dubose","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib236","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ydbio.2010.08.035","article-title":"Coffin\u2013Lowry syndrome: a role for RSK2 in mammalian neurogenesis","volume":"347","author":"Dugani","year":"2010","journal-title":"Dev. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib237","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/ejhg.2010.102","article-title":"Paternally inherited microdeletion at 15q11.2 confirms a significant role for the SNORD116C\/D box snoRNA cluster in Prader\u2013Willi syndrome","volume":"18","author":"Duker","year":"2010","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib238","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng1933","article-title":"Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders","volume":"39","author":"Durand","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib239","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/mp.2011.57","article-title":"SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism","author":"Durand","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib240","unstructured":"Ecker, C., Spooren, W., Murphy, D.G. Translational approaches to the biology of autism: false dawn or a new era? Mol. Psychiatry, in press."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib241","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.neuron.2010.01.005","article-title":"Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132","volume":"65","author":"Edbauer","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib242","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1365-2788.2009.01208.x","article-title":"From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis","volume":"53","author":"Ehninger","year":"2009","journal-title":"J.\u00a0Intellect. Disabil. Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib243","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1788","article-title":"Reversal of learning deficits in a Tsc2+\/\u2212 mouse model of tuberous sclerosis","volume":"14","author":"Ehninger","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib244","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.neuron.2008.12.007","article-title":"Reversing neurodevelopmental disorders in adults","volume":"60","author":"Ehninger","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib245","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.molmed.2010.10.002","article-title":"Rapamycin for treating tuberous sclerosis and autism spectrum disorders","volume":"17","author":"Ehninger","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib246","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/08916930802024202","article-title":"ICF, an immunodeficiency syndrome: DNA methyltransferase 3B involvement, chromosome anomalies, and gene dysregulation","volume":"41","author":"Ehrlich","year":"2008","journal-title":"Autoimmunity"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib247","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/7854_2011_144","article-title":"Epigenetics: genetics versus life experiences","volume":"9","author":"Elia","year":"2012","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib248","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/nn.2642","article-title":"Resilience to social stress coincides with functional DNA methylation of the Crf gene in adult mice","volume":"13","author":"Elliott","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib249","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1093\/brain\/awr155","article-title":"Schizophrenia is associated with dysregulation of a Cdk5 activator that regulates synaptic protein expression and cognition","volume":"134","author":"Engmann","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib250","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.biopsych.2010.09.038","article-title":"Reducing prefrontal gamma-aminobutyric acid activity induces cognitive, behavioural, and dopaminergic abnormalities that resemble schizophrenia","volume":"69","author":"Enomoto","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib251","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature09906","article-title":"Mapping and analysis of chromatin state dynamics in nine human cell types","volume":"473","author":"Ernst","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib252","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejogrb.2005.07.028","article-title":"Abnormal folate metabolism in mothers with Down syndrome offspring: review of the literature","volume":"124","author":"Eskes","year":"2005","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib253","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease","volume":"12","author":"Esteller","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib254","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nsmb.2070","article-title":"Combinatorial readout of histone H3 modifications specifies localization of ATRX to heterochromatin","volume":"18","author":"Eustermann","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib255","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/aur.175","article-title":"Behavioral profiles of mouse models for autism spectrum disorders","volume":"4","author":"Ey","year":"2011","journal-title":"Autism Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib256","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1261\/rna.2111310","article-title":"DGCR8 recognizes primary transcripts of microRNAs through highly cooperative binding and formation of higher-order structures","volume":"16","author":"Faller","year":"2010","journal-title":"RNA"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib257","doi-asserted-by":"crossref","first-page":"7332","DOI":"10.1073\/pnas.1201310109","article-title":"Genomic landscape of human allele-specific DNA methylation","volume":"109","author":"Fang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib258","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.tig.2010.02.001","article-title":"Molecular diversity through RNA editing: a balancing act","volume":"26","author":"Farajollahi","year":"2010","journal-title":"Trends Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib259","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.neuropharm.2010.11.011","article-title":"The role of fragile X mental retardation protein in major mental disorders","volume":"60","author":"Fatemi","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib260","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1002\/ar.21299","article-title":"Metabotropic glutamate receptor 5 upregulation in children with autism is associated with underexpression of both fragile X mental retardation protein and GABAA receptor beta 3 in adults with autism","volume":"294","author":"Fatemi","year":"2011","journal-title":"Anat. Rec. (Hoboken)"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib261","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev-biophys-042910-155338","article-title":"Protein folding at the exit tunnel","volume":"40","author":"Fedyukina","year":"2011","journal-title":"Annu. Rev. Biophys."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib262","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1073\/pnas.0906183107","article-title":"Stochastic epigenetic variation as a driving force of development, evolutionary adaptation, and disease","volume":"107","author":"Feinberg","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib263","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/301089a0","article-title":"Hypomethylation distinguishes genes of some human cancers from their normal counterparts","volume":"301","author":"Feinberg","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib264","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.chc.2007.03.006","article-title":"Social phenotypes in neurogenetic syndromes","volume":"16","author":"Feinstein","year":"2007","journal-title":"Child. Adolesc. Psychiatr. Clin. N. Am."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib265","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.neuropharm.2011.06.007","article-title":"Group II metabotropic glutamate receptor agonists and positive allosteric modulators as novel treatments for schizophrenia","volume":"62","author":"Fell","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib266","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1073\/pnas.1101219108","article-title":"Deficiency of Dgcr8, a gene disrupted by the 22q11.2 microdeletion, results in altered short-term plasticity in the prefrontal cortex","volume":"108","author":"Fenelon","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib267","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0074-7742(09)89004-1","article-title":"The role of DNA methylation in the central nervous system and neuropsychiatric disorders","volume":"89","author":"Feng","year":"2009","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib268","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nn.2514","article-title":"Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons","volume":"13","author":"Feng","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib269","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nsmb.1778","article-title":"PHF8 activates transcription of rRNA genes through H3K4me3 binding and H3K9me1\/2 demethylation","volume":"17","author":"Feng","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib270","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00213-009-1612-6","article-title":"Role of cannabis and endocannabinoids in the genesis of schizophrenia","volume":"206","author":"Fernandez-Espejo","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib271","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrg1767","article-title":"Structural variation in the human genome","volume":"7","author":"Feuk","year":"2006","journal-title":"Nat. Res. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib272","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/ajmg.a.34156","article-title":"Adults with Sotos syndrome: review of 21 adults with molecularly confirmed NSD1 alterations, including a detailed case report of the oldest person","volume":"155A","author":"Fickie","year":"2011","journal-title":"Am. J. Med. Genet. Part. A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib273","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cell.2012.02.013","article-title":"Histone recognition and large-scale structural analysis of the human bromodomain family","volume":"149","author":"Filippakopoulos","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1078","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/B978-0-444-54299-1.00012-1","article-title":"Gene therapy for Down syndrome","volume":"197","author":"Fillat","year":"2012","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib274","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.tips.2010.09.003","article-title":"Targeting the correct HDAC(s) to treat cognitive disorders","volume":"31","author":"Fischer","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib275","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nature04219","article-title":"Regulation of HP1-chromatin binding by histone H3 methylation and phosphorylation","volume":"438","author":"Fischle","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib276","doi-asserted-by":"crossref","first-page":"15382","DOI":"10.1073\/pnas.0707456104","article-title":"The E-protein Tcf4 interacts with Math1 to regulate differentiation of a specific subset of neuronal progenitors","volume":"104","author":"Flora","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib277","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000327329","article-title":"FOXG1-related disorders: from clinical description to molecular genetics","volume":"2","author":"Florian","year":"2012","journal-title":"Mol. Syndromol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib278","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1093\/hmg\/dds240","article-title":"RBFOX1 regulates both splicing and transcriptional networks in human neuronal development","volume":"21","author":"Fogel","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib279","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.neuropharm.2012.05.042","article-title":"Class I histone deacetylase inhibition ameliorates social cognition and cell adhesion molecule plasticity deficits in a rodent model of autism spectrum disorder","volume":"63","author":"Foley","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib280","doi-asserted-by":"crossref","first-page":"13305","DOI":"10.1523\/JNEUROSCI.3010-10.2010","article-title":"Histone H1 poly[ADP]-ribosylation regulates the chromatin alterations required for learning consolidation","volume":"30","author":"Fontan-Lozano","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib281","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/epi.6.1.13297","article-title":"Plant homeodomain fingers form a helping hand for transcription","volume":"6","author":"Fortschegger","year":"2011","journal-title":"Epigenetics"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib282","doi-asserted-by":"crossref","first-page":"10604","DOI":"10.1073\/pnas.0500398102","article-title":"Epigenetic differences arise during the lifetime of monozygotic twins","volume":"102","author":"Fraga","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib283","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2217\/epi.10.62","article-title":"Targeting epigenetic networks with polypharmacology: a new avenue to tackle cancer","volume":"2","author":"Franci","year":"2010","journal-title":"Epigenomics"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib284","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.nbd.2009.11.012","article-title":"Epigenetic inheritance in mammals: evidence for the impact of adverse environmental effects","volume":"39","author":"Franklin","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib285","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.20784","article-title":"Rapamycin causes regression of astrocytomas in tuberous sclerosis complex","volume":"59","author":"Franz","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib286","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s11910-012-0269-4","article-title":"Molecular therapies for tuberous sclerosis and neurofibromatosis","volume":"12","author":"Franz","year":"2012","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib287","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/j.1471-4159.2006.04011.x","article-title":"Loss of the cellular prion protein affects the Ca2+ homeostasis in hippocampal CA1 neurons","volume":"98","author":"Fuhrmann","year":"2006","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib288","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1262\/jrd.50.565","article-title":"Expression of Prnp mRNA (prion protein gene) in mouse spermatogenic cells","volume":"50","author":"Fujisawa","year":"2004","journal-title":"J.\u00a0Reprod. Dev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib289","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/B978-0-12-396456-4.00005-5","article-title":"Targeting phosphorylation of eukaryotic initiation factor-2alpha- to treat human disease","volume":"106","author":"Fullwood","year":"2012","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib290","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.yhbeh.2010.05.016","article-title":"Epigenomic communication systems in humans and honey bees: from molecules to behavior","volume":"59","author":"Gabor Miklos","year":"2011","journal-title":"Horm. Behav."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib291","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20110648","article-title":"MeCP2 and Rett syndrome: reversibility and potential avenues for therapy","volume":"439","author":"Gadalla","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib292","unstructured":"Gadalla, K.K., Bailey, M.E., Spike, R.C., Ross, P.D., Woodard, K.T., Kalburgi, S.N., Bachaboina, L., Deng, J.V., West, A.F., Samulski, R.J., Gray, S.J., Cobb, S.R. Improved survival and reduced phenotypic severity following AAV9 MECP2 gene transfer to neonatal and juvenile male MeCP2 knockout mice. Mol. Ther., in press."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib293","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1007\/s10803-009-0733-4","article-title":"Socio-behavioral characteristics of children with Rubinstein\u2013Taybi syndrome","volume":"39","author":"Gal\u00e9ra","year":"2009","journal-title":"J.\u00a0Autism Dev. Disord."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib294","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.tibs.2006.12.007","article-title":"Sticky fingers: zinc-fingers as protein-recognition motifs","volume":"32","author":"Gamsjaeger","year":"2007","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib295","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/nature09271","article-title":"A\u00a0novel pathway regulates memory and plasticity via SIRT1 and miR-134","volume":"466","author":"Gao","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib296","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nmeth1052","article-title":"Pervasive combinatorial modification of histone H3 in human cells","volume":"4","author":"Garcia","year":"2007","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib297","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1042\/BJ20090489","article-title":"Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR)","volume":"421","author":"Garcia-Martinez","year":"2009","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib298","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1542\/peds.2010-1036","article-title":"Perinatal and neonatal risk factors for autism: a comprehensive meta-analysis","volume":"128","author":"Gardener","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib299","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrd3179","article-title":"Targeting microRNAs in cancer: rationale, strategies and challenges","volume":"9","author":"Garzon","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib300","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4161\/epi.5.5.11999","article-title":"Epigenetic alteration of microRNAs in DNMT3B-mutated patient of ICF syndrome","volume":"5","author":"Gatto","year":"2010","journal-title":"Epigenetics"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib301","doi-asserted-by":"crossref","first-page":"7863","DOI":"10.1073\/pnas.0906232107","article-title":"De novo mutations in the gene encoding the synaptic scaffolding protein Shank3 in patients ascertained for schizophrenia","volume":"107","author":"Gauthier","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib302","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.nbd.2011.12.008","article-title":"Epigenetic and post-transcriptional dysregulation of gene expression in schizophrenia and related disease","volume":"46","author":"Gavin","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib303","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jpsychires.2008.12.006","article-title":"Histone deacetylase inhibitors and candidate gene expression: an in\u00a0vivo and in\u00a0vitro approach to studying chromatin remodeling in a clinical population","volume":"43","author":"Gavin","year":"2009","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib304","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.neubiorev.2009.10.010","article-title":"Histone modifications, DNA methylation and schizophrenia","volume":"34","author":"Gavin","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib305","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/npp.2011.221","article-title":"Growth arrest and DNA-damage-inducible, beta (GADD45b)-mediated DNA demethylation in major psychosis","volume":"37","author":"Gavin","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib306","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.tig.2009.05.002","article-title":"The genetic landscape of intellectual disability arising from chromosome X","volume":"25","author":"Gecz","year":"2009","journal-title":"Trends Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib307","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00018-011-0842-z","article-title":"Immunological aspects of 22q11.2 deletion syndrome","volume":"69","author":"Gennery","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib308","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.tics.2011.07.003","article-title":"Genetics of autism spectrum disorders","volume":"15","author":"Geschwind","year":"2011","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib309","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.brainres.2010.09.046","article-title":"Gene and miRNA expression profiles in autism spectrum disorders","volume":"1380","author":"Ghahramani Seno","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib310","doi-asserted-by":"crossref","first-page":"8743","DOI":"10.1523\/JNEUROSCI.2294-09.2009","article-title":"Phosphorylation of prion protein at serine 43 induces prion protein conformational change","volume":"29","author":"Giannopoulos","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib311","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1750-1172-1-15","article-title":"Alpha thalassaemia-mental retardation, X linked","volume":"1","author":"Gibbons","year":"2006","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib312","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/humu.20734","article-title":"Mutations in the chromatin-associated protein ATRX","volume":"29","author":"Gibbons","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib313","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.neuron.2010.08.040","article-title":"Structural MRI of pediatric brain development: what have we learned and where are we going?","volume":"67","author":"Giedd","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib314","doi-asserted-by":"crossref","first-page":"14805","DOI":"10.1523\/JNEUROSCI.1161-10.2010","article-title":"Behavioral and cerebellar transmission deficits in mice lacking the autism-linked gene islet brain-2","volume":"30","author":"Giza","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib315","unstructured":"Glausier, J.R., Lewis, D.A. Dendritic spine pathology in schizophrenia. Neuroscience, in press."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib316","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nature07953","article-title":"Autism genome-wide copy number variation reveals ubiquitin and neuronal genes","volume":"459","author":"Glessner","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib317","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/JCP.0b013e3181a443d0","article-title":"A\u00a0double-blind randomized trial of mood stabilizer augmentation using lamotrigine and valproate for patients with schizophrenia who are stabilized and partially responsive","volume":"29","author":"Glick","year":"2009","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib318","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.neubiorev.2009.11.017","article-title":"Circadian rhythms and sleep in children with autism","volume":"34","author":"Glickman","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib319","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.gene.2005.09.010","article-title":"Acetylation and deacetylation of non-histone proteins","volume":"363","author":"Glozak","year":"2005","journal-title":"Gene"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib320","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nn.2997","article-title":"Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses","volume":"15","author":"Goffin","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib321","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nature11091","article-title":"KCTD13 is a major driver of mirrored neuroanatomical phenotypes of the 16p11.2 copy number variant","volume":"485","author":"Golzio","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib322","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4161\/pri.2.2.6988","article-title":"The peculiar interaction between mammalian prion protein and RNA","volume":"2","author":"Gomes","year":"2008","journal-title":"Prion"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib323","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1111\/j.1476-5381.2011.01489.x","article-title":"Antidepressant-like effect induced by systemic and intra-hippocampal administration of DNA methylation inhibitors","volume":"164","author":"Gomes","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib324","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1128\/MCB.06728-11","article-title":"Phosphorylation of distinct sites in MeCP2 modifies cofactor associations and the dynamics of transcriptional regulation","volume":"32","author":"Gonzales","year":"2012","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib325","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11920-010-0097-7","article-title":"The role of MeCP2 in brain development and neurodevelopmental disorders","volume":"12","author":"Gonzales","year":"2010","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib326","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11920-010-0124-8","article-title":"Alterations of cortical GABA neurons and network oscillations in schizophrenia","volume":"12","author":"Gonzalez-Burgos","year":"2010","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib327","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature06612","article-title":"Identification of a serotonin\/glutamate receptor complex implicated in psychosis","volume":"452","author":"Gonzalez-Maeso","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib328","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ana.21317","article-title":"Cognitive deficits in Tscl+\/\u2212 mice in the absence of cerebral lesions and seizures","volume":"62","author":"Goorden","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib329","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2006.08.006","article-title":"Parent-of-origin effects in attention-deficit hyperactivity disorder","volume":"149","author":"Goos","year":"2007","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib330","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ddrr.9","article-title":"Genes, brain development and psychiatric phenotypes in velo-cardio-facial syndrome","volume":"14","author":"Gothelf","year":"2008","journal-title":"Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib331","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jchemneu.2011.09.002","article-title":"Alterations of brain circuits in Down syndrome murine models","volume":"42","author":"Gotti","year":"2011","journal-title":"J.\u00a0Chem. Neuroanat."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib332","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.tcb.2011.07.003","article-title":"Postsynaptic ProSAP\/shank scaffolds in the cross-hair of synaptopathies","volume":"21","author":"Grabrucker","year":"2011","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib333","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1101\/lm.1766510","article-title":"Protein phosphatase 1-dependent transcriptional programs for long-term memory and plasticity","volume":"17","author":"Graff","year":"2010","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib334","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1460-9568.2009.06787.x","article-title":"Epigenetic dysregulation in cognitive disorders","volume":"30","author":"Graff","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib335","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ncomms1997","article-title":"Dynamic histone marks in the hippocampus and cortex facilitate memory consolidation","volume":"3","author":"Gr\u00e4ff","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib336","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jaac.2010.05.005","article-title":"Autism spectrum disorders and epigenetics","volume":"49","author":"Grafodatskaya","year":"2010","journal-title":"J.\u00a0Am. Acad. Child. Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib337","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1242\/dev.041061","article-title":"The mirR-124-Sox9 paramutation: RNA-mediated epigenetic control of embryonic and adult growth","volume":"136","author":"Grandjean","year":"2009","journal-title":"Development"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib338","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2217\/epi.11.67","article-title":"Epigenetic treatment of neurological disease","volume":"3","author":"Gray","year":"2011","journal-title":"Epigenomics"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib339","unstructured":"Gray, S.J. Gene therapy and neurodevelopmental disorders. Neuropharmacology, in\u00a0press."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib340","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pharmthera.2005.01.007","article-title":"The human reelin gene: transcription factors (+), repressors (\u2212) and the methylation switch (+\/\u2212) in schizophrenia","volume":"111","author":"Grayson","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib341","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/npp.2012.125","article-title":"The dynamics of DNA methylation in schizophrenia and related psychiatric disorders","volume":"38","author":"Grayson","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib342","doi-asserted-by":"crossref","first-page":"9341","DOI":"10.1073\/pnas.0503736102","article-title":"Reelin promoter hypermethylation in schizophrenia","volume":"102","author":"Grayson","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib343","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1124\/mol.109.061333","article-title":"Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders?","volume":"77","author":"Grayson","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib344","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pneurobio.2012.07.005","article-title":"Copy number variations in neurodevelopmental disorders","volume":"99","author":"Grayton","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib345","unstructured":"Green, M.J., Cairns, M.J., Wu, J., Dragovic, M., Jablensky, A., Tooney, P.A., Scott, R.J., Carr, V.J. Genome-wide supported variant MIR137 and severe negative symptoms predict membership of an impaired cognitive subtype of schizophrenia. Mol. Pharmacol., in press."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib346","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2010.01.026","article-title":"The Angelman syndrome protein Ube3a regulates synapse development by ubiquitinating arc","volume":"140","author":"Greer","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib347","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1126\/science.1190831","article-title":"Sex-specific parent-of-origin allelic expression in the mouse brain","volume":"329","author":"Gregg","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib348","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1190830","article-title":"High-resolution analysis of parent-of-origin allelic expression in the mouse brain","volume":"329","author":"Gregg","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib349","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1741-7015-7-62","article-title":"Genomic and epigenetic evidence for oxytocin receptor deficiency in autism","volume":"7","author":"Gregory","year":"2009","journal-title":"BMC Med."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib350","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/humu.22072","article-title":"Rett networked database: an integrated clinical and genetic network of Rett syndrome databases","volume":"33","author":"Grillo","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib351","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1098\/rspb.2003.2485","article-title":"Immune function across generations: integrating mechanism and evolutionary process in maternal antibody transmission","volume":"270","author":"Grindstaff","year":"2003","journal-title":"Proc. Biol. Sci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib352","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1093\/hmg\/dds164","article-title":"Evaluation of copy number variations reveals novel candidate genes in autism spectrum disorder-associated pathways","volume":"21","author":"Griswold","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib353","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.biopsych.2007.06.002","article-title":"CRF1 not glucocorticoid receptors mediate prepulse inhibition deficits in mice overexpressing CRF","volume":"63","author":"Groenink","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib354","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/DBP.0b013e3181ee384e","article-title":"Epigenetics, copy number variation, and other molecular mechanisms underlying neurodevelopmental disabilities: new insights and diagnostic approaches","volume":"31","author":"Gropman","year":"2010","journal-title":"J.\u00a0Dev. Behav. Pediatr."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib355","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrd3577","article-title":"Induced pluripotent stem cells \u2013 opportunities for disease modeling and drug discovery","volume":"10","author":"Grskovic","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib356","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature07925","article-title":"HDAC2 negatively regulates memory formation and synaptic plasticity","volume":"459","author":"Guan","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib357","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.neuropharm.2010.10.021","article-title":"Epigenetic GABAergic targets in schizophrenia and bipolar disorder","volume":"60","author":"Guidotti","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib358","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.tips.2008.10.010","article-title":"Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling","volume":"30","author":"Guidotti","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib359","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/archgenpsychiatry.2009.80","article-title":"Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation","volume":"66","author":"Guilmatre","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib360","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1600-0412.2011.01325.x","article-title":"Pre-, peri- and neonatal risk factors for autism","volume":"91","author":"Guinchat","year":"2012","journal-title":"Acta. Obstet. Gynecol. Scand."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib361","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.cell.2011.03.022","article-title":"Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain","volume":"145","author":"Guo","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib362","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1523\/JNEUROSCI.3732-09.2010","article-title":"Histone methylation regulates memory formation","volume":"30","author":"Gupta","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib363","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1523\/JNEUROSCI.0147-12.2012","article-title":"G9a\/GLP histone lysine dimethyltransferase complex activity in the hippocampus and the entorhinal cortex is required for gene activation and silencing during memory consolidation","volume":"32","author":"Gupta-Agarwal","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib364","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nature07672","article-title":"Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals","volume":"458","author":"Guttman","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib365","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.1138389","article-title":"Reversal of neurological defects in a mouse model of Rett syndrome","volume":"315","author":"Guy","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib366","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1517\/17425250902911455","article-title":"A\u00a0review of valproate in psychiatric practice","volume":"5","author":"Haddad","year":"2009","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib367","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1101\/lm.1986911","article-title":"HDAC inhibition modulates hippocampus-dependent long-term memory for object location in a CBP-dependent manner","volume":"18","author":"Haettig","year":"2011","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib368","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/978-3-642-21649-7_17","article-title":"Fragile X syndrome and targeted treatment trials","volume":"54","author":"Hagerman","year":"2012","journal-title":"Results Probl. Cell. Differ."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib369","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neuropharm.2012.05.050","article-title":"The potential of nicotinic enhancement of cognitive remediation training in schizophrenia","volume":"64","author":"Hahn","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib370","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1101\/sqb.2004.69.67","article-title":"The (dual) origin of epigenetics","volume":"69","author":"Haig","year":"2004","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib371","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0925-4773(02)00181-8","article-title":"Epigenetic reprogramming in mouse primordial germ cells","volume":"117","author":"Hajkova","year":"2002","journal-title":"Mech. Dev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib372","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nature10875","article-title":"Prions are a common mechanism for phenotypic inheritance in wild yeasts","volume":"482","author":"Haffmann","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib373","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-3-642-24716-3_16","article-title":"5-HT(2C) receptor agonists and the control of appetite","author":"Halford","year":"2012","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib374","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.sbi.2005.04.004","article-title":"Multiple modes of RNA recognition by zinc finger proteins","volume":"15","author":"Hall","year":"2005","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib375","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/archgenpsychiatry.2011.76","article-title":"Genetic heritability and shared environmental factors among twin pairs with autism","volume":"68","author":"Hallmayer","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib376","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000323732","article-title":"Developmental expression mapping of a gene implicated in multiple neurodevelopmental disorders, A2bp1 (Fox1)","volume":"33","author":"Hammock","year":"2011","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib377","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nature08162","article-title":"Distinctive chromatin in human sperm packages genes for embryo development","volume":"460","author":"Hammoud","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib378","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.febslet.2011.02.001","article-title":"TSC1\/TSC2 signaling in the CNS","volume":"585","author":"Han","year":"2011","journal-title":"FEBS Lett."},{"issue":"11","key":"10.1016\/j.neuropharm.2012.11.015_bib379","doi-asserted-by":"crossref","first-page":"e15497","DOI":"10.1371\/journal.pone.0015497","article-title":"Transgenic miR132 alters neuronal spine density and impairs novel object recognition memory","volume":"5","author":"Hansen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib380","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/ncb1787","article-title":"A\u00a0model for transmission of the H3K27me3 epigenetic mark","volume":"10","author":"Hansen","year":"2008","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib381","doi-asserted-by":"crossref","first-page":"14412","DOI":"10.1073\/pnas.96.25.14412","article-title":"The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome","volume":"96","author":"Hansen","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib382","doi-asserted-by":"crossref","first-page":"e873","DOI":"10.1371\/journal.pone.0000873","article-title":"Brain expressed microRNAs implicated in schizophrenia etiology","volume":"2","author":"Hansen","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib383","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1098\/rstb.2009.0009","article-title":"The beautiful otherness of the autistic mind","volume":"364","author":"Happe","year":"2009","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib384","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.beem.2011.05.009","article-title":"Vitamin D and the brain","volume":"25","author":"Harms","year":"2011","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib385","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1098\/rstb.2008.0137","article-title":"Maternal transfer of antibodies in vertebrates: trans-generational effects on offspring immunity","volume":"364","author":"Hasselquist","year":"2009","journal-title":"Philos. Trans. R. Soc. Lond."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib386","doi-asserted-by":"crossref","first-page":"11489","DOI":"10.1073\/pnas.0705003104","article-title":"Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice","volume":"104","author":"Hayashi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib387","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4161\/cib.4.2.14492","article-title":"Re-addressing synaptic pruning theory for schizophrenia: combination of brain imaging and cell biology","volume":"4","author":"Hayashi-Takagi","year":"2011","journal-title":"Commun. Integr. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib388","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.tins.2011.11.001","article-title":"Trisomy 21 and early brain development","volume":"35","author":"Haydar","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib389","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1101\/gad.17153811","article-title":"The caenorhabtitis elegans SOMI-1 zinc finger protein and SW1\/SNF promote regulation of development by the miR-84 microRNA","volume":"25","author":"Hayes","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1079","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/B978-0-444-54299-1.00009-1","article-title":"The in vivo Down syndrome genomic library in mouse","volume":"197","author":"Herault","year":"2012","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib390","doi-asserted-by":"crossref","first-page":"17046","DOI":"10.1073\/pnas.0806560105","article-title":"Persistent epigenetic differences associated with prenatal exposure to famine in humans","volume":"105","author":"Heijmans","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib391","doi-asserted-by":"crossref","first-page":"152ra128","DOI":"10.1126\/scitranslmed.3004218","article-title":"Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen","volume":"19","author":"Henderson","year":"2012","journal-title":"Sci.Transl. Med."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib392","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1126\/science.1146282","article-title":"Humans have evolved specialized skills of social cognition: the cultural intelligence hypothesis","volume":"317","author":"Herrmann","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib393","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.tins.2012.01.002","article-title":"Emerging roles of the neuronal nucleolus","volume":"35","author":"Hetman","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib394","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1016\/j.yexcr.2010.05.028","article-title":"Core histone H2A ubiquitylation and transcriptional regulation","volume":"316","author":"Higashi","year":"2010","journal-title":"Exp. Cell. Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib395","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1002\/ajmg.a.33969","article-title":"Craniofacial and oral features of Sotos syndrome","volume":"155A","author":"Hirai","year":"2011","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib396","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/GIM.0b013e3181ac9aea","article-title":"PTEN hamartoma tumor syndrome: an overview","volume":"11","author":"Hobert","year":"2009","journal-title":"Genet. Med."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib397","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.tins.2009.11.003","article-title":"mTOR signaling: at the crossroads of plasticity, memory and disease","volume":"33","author":"Hoeffer","year":"2010","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib398","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1601-183X.2012.00768.x","article-title":"Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome","volume":"11","author":"Hoeffer","year":"2012","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib399","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/jmg.2008.061580","article-title":"Chromosome 15q11\u201313 duplication syndrome brain reveals epigenetic alterations in gene expression not predicted from copy number","volume":"46","author":"Hogart","year":"2009","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib400","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2174\/138161212799316280","article-title":"Stress and the prodromal phase of psychosis","volume":"18","author":"Holtzman","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib401","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1002\/ajmg.a.32364","article-title":"Mechanisms of imprinting of the Prader\u2013Willi\/Angelman region","volume":"146A","author":"Horsthemke","year":"2008","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib402","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.bbrc.2007.11.163","article-title":"A\u00a0monoclonal antibody (1D12) defines novel distribution patterns of prion protein (PrP) as granules in nucleus","volume":"366","author":"Hosokawa","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib403","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.tibs.2012.02.009","article-title":"The spliceosome: a flexible, reversible macromolecular machine","volume":"37","author":"Hoskins","year":"2012","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib404","doi-asserted-by":"crossref","first-page":"928","DOI":"10.4161\/epi.6.7.16263","article-title":"Methylation variation at IGF2 differentially methylated regions and maternal folic acid use before and during pregnancy","volume":"6","author":"Hoyo","year":"2011","journal-title":"Epigenetics"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib405","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11373-007-9158-2","article-title":"Neurofibromin signaling and synapses","volume":"14","author":"Hsueh","year":"2007","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1080","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1093\/hmg\/ddn165","article-title":"Regulation of DNA methylation activity through Dnmt3L promoter methylation by Dnmt3 enzymes in embryonic development","volume":"17","author":"Hu","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1081","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1042\/BST0390446","article-title":"Differing effects of rapamycin and mTOR kinase inhibitors on protein synthesis","volume":"39","author":"Huo","year":"2011","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib406","doi-asserted-by":"crossref","first-page":"7199","DOI":"10.1523\/JNEUROSCI.1779-05.2005","article-title":"The mRNA for elongation factor 1 alpha is localized in dendrites and translated in response to treatments that induce long-term depression","volume":"25","author":"Huang","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib407","doi-asserted-by":"crossref","first-page":"e809","DOI":"10.1371\/journal.pone.0000809","article-title":"GAD1 mRNA expression and DNA methylation in prefrontal cortex of subjects with schizophrenia","volume":"2","author":"Huang","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib408","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature10726","article-title":"Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons","volume":"481","author":"Huang","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib409","doi-asserted-by":"crossref","first-page":"11254","DOI":"10.1523\/JNEUROSCI.3272-07.2007","article-title":"Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters","volume":"27","author":"Huang","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib410","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1128\/MCB.00969-10","article-title":"P21-activated kinases 1 and 3 control brain size through coordinating neuronal complexity and synaptic properties","volume":"31","author":"Huang","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib411","series-title":"GeneReviews\u2122 [Internet]","article-title":"Coffin\u2013Lowry syndrome","author":"Hunter","year":"2009"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib412","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/npp.2011.190","article-title":"Differential regulation of MeCP2 phosphorylation in the CNS by dopamine and serotonin","volume":"37","author":"Hutchinson","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib413","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1042\/BST20110682","article-title":"Roles of the mammalian target of rapamycin, mTOR, in controlling ribosome biogenesis and protein synthesis","volume":"40","author":"Iadevaia","year":"2012","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib414","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1093\/nar\/gkr1040","article-title":"mTOR signaling regulates the processing of pre-rRNA in human cells","volume":"40","author":"Iadevaia","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib415","doi-asserted-by":"crossref","first-page":"6908","DOI":"10.1158\/0008-5472.CAN-08-1107","article-title":"PTEN acetylation modulates its interaction with PDZ domain","volume":"68","author":"Ikenoue","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib416","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/nn.2615","article-title":"MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212","volume":"13","author":"Im","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib417","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.tins.2012.01.004","article-title":"MicroRNAs in neuronal function and dysfunction","volume":"35","author":"Im","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib418","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.mcn.2009.10.005","article-title":"An activity-induced microRNA controls dendritic spine formation by regulating Rac1-PAK signaling","volume":"43","author":"Impey","year":"2010","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib419","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1176\/appi.ajp.2010.09111660","article-title":"Maternally derived microduplications at 15q11\u2013q13 implication of psychotic genes in psychotic illness","volume":"168","author":"Ingason","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib420","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/mp.2009.101","article-title":"Copy number variations of chromosome 16p13.1 region associated with schizophrenia","volume":"16","author":"Ingason","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib421","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.neuron.2010.03.005","article-title":"The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior","volume":"65","author":"Insel","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib422","doi-asserted-by":"crossref","first-page":"13859","DOI":"10.1074\/jbc.M111.309864","article-title":"Methyl CpG-binding protein isoform MeCP2-e2 is dispensable for Rett syndrome phenotypes but essential for embryo viability and placenta development","volume":"287","author":"Itoh","year":"2012","journal-title":"Biol. Chem."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib423","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1523\/JNEUROSCI.0766-05.2005","article-title":"DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia","volume":"25","author":"Iwamoto","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib424","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nsmb.2062","article-title":"ATRX ADD domain links an atypical histone methylation recognition mechanism to human mental-retardation syndrome","volume":"18","author":"Iwase","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1082","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.cell.2007.02.017","article-title":"The X-linked mental retardation gene SMCX\/JARID1C defines a family of histone H3 lysine 4 demethylases","volume":"128","author":"Iwase","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib425","doi-asserted-by":"crossref","first-page":"64ra1","DOI":"10.1126\/scitranslmed.3001708","article-title":"Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056","volume":"3","author":"Jacquemont","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib426","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/710943","article-title":"Understanding the pathogenesis of Angelman syndrome through animal models","volume":"2012","author":"Jana","year":"2012","journal-title":"Neural Plast."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib427","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/humu.22086","article-title":"Mutation update on the CHD7 gene involved in CHARGE syndrome","volume":"33","author":"Janssen","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib428","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1086\/427563","article-title":"Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation","volume":"76","author":"Jensen","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib429","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2202-11-19","article-title":"Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome\/X-linked mental retardation","volume":"11","author":"Jentarra","year":"2010","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib430","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrd1087","article-title":"Drug discovery with engineered zinc-finger proteins","volume":"2","author":"Jamieson","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib431","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrg2522","article-title":"Nucleosome positioning and gene regulation: advances through genomics","volume":"10","author":"Jiang","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib432","doi-asserted-by":"crossref","first-page":"e12278","DOI":"10.1371\/journal.pone.0012278","article-title":"Altered ultrasonic vocalization and impaired learning and memory in Angelman syndrome mouse model with a large maternal deletion from Ube3a to Gabrb3","volume":"5","author":"Jiang","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib433","doi-asserted-by":"crossref","first-page":"7152","DOI":"10.1523\/JNEUROSCI.1314-10.2010","article-title":"Setdb1 histone methyltransferase regulates mood-related behaviors and expression of the NMDA receptor subunit NR2B","volume":"30","author":"Jiang","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib434","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/hmg\/ddm341","article-title":"DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function","volume":"17","author":"Jin","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib435","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1093\/nar\/gkr120","article-title":"Genomic mapping of 5-hydroxymethylcytosine in the human brain","volume":"39","author":"Jin","year":"2011","journal-title":"Nucleic Acids Rev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib436","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.0503224102","article-title":"The NF1 tumor suppressor critically regulates TSC2 and mTOR","volume":"102","author":"Johannessen","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib437","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1017\/S0012162206000090","article-title":"Autism spectrum disorders and underlying brain pathology in CHARGE association","volume":"48","author":"Johansson","year":"2006","journal-title":"Dev. Med. Child. Neurol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib438","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1530\/REP-10-0322","article-title":"The sperm nucleus: chromatin, RNA, and the nuclear matrix","volume":"141","author":"Johnson","year":"2011","journal-title":"Reproduction"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib439","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1261\/rna.1127009","article-title":"Regulation of neural macroRNAs by the transcriptional repressor REST","volume":"15","author":"Johnson","year":"2009","journal-title":"RNA"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib440","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/hmg\/ddn026","article-title":"Targeted delivery of a Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient mice","volume":"17","author":"Jugloff","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib441","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pharmthera.2011.10.002","article-title":"MicroRNAs in neurodegenerative diseases and their therapeutic potential","volume":"133","author":"Junn","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib442","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.sbi.2010.09.012","article-title":"Reading, writing and editing methylated lysines on histone tails: new insights from recent structural studies","volume":"20","author":"Justin","year":"2010","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib443","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/hmg\/ddg039","article-title":"Loss of CBP acetyltransferase activity by PHD finger mutations in Rubinstein\u2013Taybi syndrome","volume":"12","author":"Kaldhoven","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib444","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.biopsych.2012.01.021","article-title":"Reversal of impaired hippocampal long-term potentiation and contextual fear memory deficits in Angelman syndrome model in Mice by ErbB Inhibitors","volume":"72","author":"Kaphzan","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib445","first-page":"1","article-title":"Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid","volume":"18","author":"Kataoka","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib446","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nrd2681","article-title":"Therapeutic application of histone deacetylase inhibitors for central nervous system disorders","volume":"7","author":"Kazantsev","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib447","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.bbagrm.2011.09.007","article-title":"Histone chaperones link histone nuclear import and chromatin assembly","volume":"1819","author":"Keck","year":"2012","journal-title":"Biochem. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib448","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1017\/S0140525X06009095","article-title":"Resolving the paradox of common, harmful, heritable mental disorders: which evolutionary genetic models work best?","volume":"29","author":"Keller","year":"2006","journal-title":"Behav. Brain Sci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib449","doi-asserted-by":"crossref","first-page":"e1001212","DOI":"10.1371\/journal.pgen.1001212","article-title":"Altered DNA methylation in leukocytes with trisomy 21","volume":"18","author":"Kerkel","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib450","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.devcel.2009.12.017","article-title":"ATRX partners with cohesion and MeCP2 and contributes to developmental silencing of imprinted genes in the brain","volume":"18","author":"Kernohan","year":"2010","journal-title":"Dev. Cell."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib451","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ejhg.2011.145","article-title":"Transgenic complementation of MeCP2 deficiency: phenotypic rescue of Mecp2-null mice by isoform-specific transgenes","volume":"20","author":"Kerr","year":"2012","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib452","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.mad.2011.02.003","article-title":"CUL4B-deficiency in humans: understanding the clinical consequences of impaired Cullin 4-RING E3 ubiquitin ligase function","volume":"132","author":"Kerzendorfer","year":"2011","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib453","doi-asserted-by":"crossref","first-page":"e1486","DOI":"10.1371\/journal.pone.0001486","article-title":"A\u00a0novel RNA transcript with antiapoptotic function is silenced in fragile X syndrome","volume":"3","author":"Khalil","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib454","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.schres.2012.06.038","article-title":"Experimental validation of candidate schizophrenia gene ZNF804A as target for hsa-miR-137","volume":"141","author":"Kim","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib455","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nrm2632","article-title":"Biogenesis of small RNAs in animals","volume":"10","author":"Kim","year":"2009","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib456","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fnmol.2011.00044","article-title":"Functions of GSK-3 signaling in development of the nervous system","volume":"4","author":"Kim","year":"2011","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib457","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/978-3-7091-0932-8_13","article-title":"Dendritic mRNA targeting and translation","volume":"970","author":"Kindler","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib458","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.chc.2005.08.005","article-title":"An update on pharmacologic treatment for autism spectrum disorders","volume":"15","author":"King","year":"2006","journal-title":"Child. Adolesc. Psychiatr. Clin. N. Am."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib459","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brainres.2010.11.031","article-title":"Is schizophrenia on the autism spectrum?","volume":"1360","author":"King","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib460","doi-asserted-by":"crossref","first-page":"C242","DOI":"10.1152\/ajpcell.00492.2008","article-title":"Histone H3 as a novel substrate for MAP kinase phosphatase-1","volume":"296","author":"Kinney","year":"2009","journal-title":"Am. J. Physiol., Cell. Physiol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib461","doi-asserted-by":"crossref","first-page":"279834","DOI":"10.1155\/2012\/279834","article-title":"Synaptic plasticity and learning in animal models of tuberous sclerosis complex","volume":"2012","author":"Kirschstein","year":"2012","journal-title":"Neural Plast."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib462","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1101\/sqb.2006.71.024","article-title":"Regulation of alternative splicing by snoRNAs","volume":"71","author":"Kishore","year":"2006","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib463","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4161\/rna.7.4.12746","article-title":"Regulation of alternative splicing by short non-coding nuclear RNAs","volume":"7","author":"Khanna","year":"2010","journal-title":"RNA Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib464","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/505693","article-title":"Loss of function mutations in euchromatin histone methyl transferase 1 (EHMT1) cause the 9q34 subtelomeric deletion syndrome","volume":"79","author":"Kleefstra","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib465","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ajhg.2012.05.003","article-title":"Disruption of an EHMT1-associated chromatin-modification module causes intellectual disability","volume":"91","author":"Kleefstra","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib466","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/jmg.2004.028464","article-title":"Disruption of the gene euchromatin histone methyl transferase1 (Eu-HMTase1) is associated with the 9q34 subtelomeric deletion syndrome","volume":"42","author":"Kleefstra","year":"2005","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib467","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/jmg.2008.062950","article-title":"Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype","volume":"46","author":"Kleefstra","year":"2009","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib468","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2040-2392-3-9","article-title":"Common genetic variants, acting additively, are a major source of risk for autism","volume":"3","author":"Klei","year":"2012","journal-title":"Mol. Autism"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib469","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/nn2010","article-title":"Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA","volume":"10","author":"Klein","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib470","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/ng.830","article-title":"Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss","volume":"43","author":"Klein","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib471","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.molcel.2010.03.002","article-title":"A\u00a0functional link between the histone demethylase PHF8 and the transcription factor ZNF711 in X-linked mental retardation","volume":"38","author":"Kleine-Kohlbrecher","year":"2010","journal-title":"Mol. Cell."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib472","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0033583510000089","article-title":"The discovery of zinc fingers and their development for practical applications in gene regulation an genome manipulation","volume":"43","author":"Klug","year":"2010","journal-title":"Q.\u00a0Rev. Biophys."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib473","doi-asserted-by":"crossref","first-page":"e29275","DOI":"10.1371\/journal.pone.0029275","article-title":"Rapid generation of microRNA sponges for microRNA inhibition","volume":"7","author":"Kluiver","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib474","unstructured":"Kneeland, R.E., Fatemi, S.H. Viral infection, inflammation and schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry, in press."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib475","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1042\/BST0350245","article-title":"Chemically targeting the PI3K family","volume":"35","author":"Knight","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib476","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.pneurobio.2010.04.002","article-title":"Reelin-mediated signaling in neuropsychiatric and neurodegenerative diseases","volume":"91","author":"Knuesel","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib477","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0140-6736(07)61601-8","article-title":"Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes","volume":"370","author":"Kobrynski","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib478","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1073\/pnas.0805854106","article-title":"MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction","volume":"106","author":"Kocerha","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib479","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.neuron.2005.07.005","article-title":"Deletion of fMRI in Purkinje cells enhances parallel fiber LTD enlarges spines, and attenuates cerebellar eyelid conditioning in fragile X syndrome","volume":"47","author":"Koekkoek","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib480","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1242\/dev.030403","article-title":"The function of non-coding RNAs in genomic imprinting","volume":"136","author":"Koerner","year":"2009","journal-title":"Development"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib481","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1093\/hmg\/ddp166","article-title":"Involvement of SMARCA2\/BRM in the SWI\/SNF chromatin-remodeling complex in schizophrenia","volume":"18","author":"Koga","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib482","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.neuroscience.2009.07.021","article-title":"Prenatal exposure to valproic acid leads to reduced expression of synaptic adhesion molecule neuroligin 3 in mice","volume":"163","author":"Kolozsi","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib483","first-page":"471","article-title":"Rate of de novo mutations and the importance of father's age to disease risk","volume":"41","author":"Kong","year":"2012","journal-title":"Nat. Gen."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib484","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1038\/mp.2011.60","article-title":"Modeling the functional genomics of autism using human neurons","volume":"17","author":"Konopka","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib485","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1745-6150-4-42","article-title":"Is evolution Darwinian or\/and Lamarckian?","volume":"4","author":"Koonin","year":"2009","journal-title":"Biol. Direct"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib486","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4161\/pri.18989","article-title":"Aggregated proteins in schizophrenia and other chronic mental diseases","volume":"6","author":"Korth","year":"2012","journal-title":"Prion"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib487","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.neuron.2004.06.002","article-title":"CBP histone acetyltransferase activity is a critical component of memory consolidation","volume":"42","author":"Korzus","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib488","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1017\/S1461145711001672","volume":"15","author":"Koseki","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib489","doi-asserted-by":"crossref","first-page":"13079","DOI":"10.1523\/JNEUROSCI.3610-09.2009","article-title":"Protein phosphatase 1 regulates the histone code for long-term memory","volume":"29","author":"Koshibu","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib490","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neuroscience.2010.11.023","article-title":"Nuclear protein phosphatase-1: an epigenetic regulator of fear memory and amygdala long-term potentiation","volume":"173","author":"Koshibu","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib491","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1073\/pnas.0509333103","article-title":"The chromatoid body of male germ cells: similarity with processing bodies and presence of dicer and microRNA pathway components","volume":"103","author":"Kotaja","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib492","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin modifications and their function","volume":"128","author":"Kouzarides","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib493","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jama.300.3.287","article-title":"Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized, controlled trial","volume":"300","author":"Krab","year":"2008","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib494","doi-asserted-by":"crossref","unstructured":"Krakowiak, P., Walker, C.K., Bremer, A.A., Baker, A.S., Ozonoff, S., Hansen, R.L., Hertz-Picciotto, I. Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders. Pediatrics 129, in press.","DOI":"10.1542\/peds.2011-2583"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib495","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nsmb.1614","article-title":"The ribosome as a platform for co-translational processing, folding and targeting of newly synthesized proteins","volume":"16","author":"Kramer","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib496","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.biocel.2008.08.009","article-title":"Genetic and epigenetic defects in mental retardation","volume":"41","author":"Kramer","year":"2009","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib497","doi-asserted-by":"crossref","first-page":"e1000569","DOI":"10.1371\/journal.pbio.1000569","article-title":"Epigenetic regulation of learning and memory by drosophila EHMT\/G9a","volume":"9","author":"Kramer","year":"2011","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib498","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1093\/humrep\/der329","article-title":"A\u00a0survey of small RNAs in human sperm","volume":"26","author":"Krawetz","year":"2011","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib499","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1093\/nar\/gkh349","article-title":"The major form of MeCP2 has a novel N-terminus generated by alternative splicing","volume":"32","author":"Kriaucionis","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib500","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.1169786","article-title":"The nuclear DNA base, 5-hydroxymethylcytosine is present in brain and enriched in Purkinje neurons","volume":"324","author":"Kriaucionis","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib501","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.molcel.2010.06.017","article-title":"The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets","volume":"39","author":"Krishnakumar","year":"2010","journal-title":"Mol. Cell."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib502","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib503","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2165\/00148581-200810050-00004","article-title":"Current management of tuberous sclerosis complex","volume":"10","author":"Krueger","year":"2008","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib504","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1073\/pnas.1013855108","article-title":"Cognitive dysfunction and prefrontal synaptic abnormalities in a mouse model of fragile X syndrome","volume":"108","author":"Krueger","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib505","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4161\/cc.8.3.7555","article-title":"PI3K\/mTORC1 activation in hamartoma syndromes: therapeutic prospects","volume":"8","author":"Krymskaya","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib506","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.molcel.2007.01.017","article-title":"Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase","volume":"25","author":"Kubicek","year":"2007","journal-title":"Mol. Cell."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib507","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1126\/science.1153069","article-title":"Nutritional control of reproductive status in honeybees via DNA methylation","volume":"319","author":"Kucharski","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib508","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1074\/jbc.M109.033407","article-title":"Chromosome 21-derived microRNAs provide an etiological basis for aberrant protein expression in human Down syndrome brains","volume":"285","author":"Kuhn","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib509","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.neuron.2005.09.023","article-title":"Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum","volume":"48","author":"Kumar","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib510","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11568-009-9028-2","article-title":"Disorders of the genome architecture: a review","volume":"2","author":"Kumar","year":"2008","journal-title":"Genomic Med."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib511","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1124\/mol.106.030635","article-title":"DNA methyltransferase inhibitors coordinately induce expression of the human reelin and glutamic acid decarboxylase 67 genes","volume":"71","author":"Kundakovic","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib512","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/mol.108.051763","article-title":"The reelin and gad67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes","volume":"75","author":"Kundakovic","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib513","doi-asserted-by":"crossref","DOI":"10.1038\/nn.3181","article-title":"HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity","author":"Kurita","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib514","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1586\/ern.12.71","article-title":"Cognitive remediation for schizophrenia: current status, biological correlates and predictors of response","volume":"12","author":"Kurtz","year":"2012","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib515","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1523\/JNEUROSCI.1262-06.2006","article-title":"Necdin promotes GABAergic neuron differentiation in cooperation with dix homeodomain proteins","volume":"26","author":"Kuwajima","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib516","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.neuron.2006.03.023","article-title":"Pten regulates neuronal arborization and social interaction in mice","volume":"50","author":"Kwon","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib517","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/mp.2011.170","article-title":"Validation of schizophrenia-associated genes CSMD1, C10orf26, CACNAC1C and TCF4 as mirR-137 targets","volume":"18","author":"Kwon","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib518","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0955-0674(02)00335-6","article-title":"The many faces of histone lysine methylation","volume":"14","author":"Lachner","year":"2002","journal-title":"Curr. Opin. Cell. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib519","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1093\/hmg\/ddm293","article-title":"An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in permutation carriers but silenced in full mutation individuals","volume":"16","author":"Ladd","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib520","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/hmg\/10.4.329","article-title":"Evidence that fragile X mental retardation protein is a negative regulator of translation","volume":"10","author":"Laggerbauer","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib521","doi-asserted-by":"crossref","first-page":"e21635","DOI":"10.1371\/journal.pone.0021635","article-title":"MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia","volume":"6","author":"Lai","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib522","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/ejhg.2012.41","article-title":"DNA replication is altered in Immunodeficiency Centromeric instability Facial anomalies (ICF) cells carrying DNMT3B mutations","volume":"20","author":"Lana","year":"2012","journal-title":"Eur. J. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib523","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/gene.10168","article-title":"Resistance of IAPs to methylation reprogramming may provide a mechanism for epigenetic inheritance in the mouse","volume":"35","author":"Lane","year":"2003","journal-title":"Genesis"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib524","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1016\/j.transproceed.2009.08.050","article-title":"Immunosuppression using the mammalian target of rapamycin (mTOR) inhibitor everolimus: pilot study shows significant cognitive and affective improvement","volume":"41","author":"Lang","year":"2009","journal-title":"Transplanation Proc."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib525","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/nn.2619","article-title":"Dnmt3a regulates emotional behavior and spine plasticity in the nucleus accumbens","volume":"13","author":"LaPlant","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib526","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/hup.1236","article-title":"Effects of adjunct valproic acid on clinical symptoms and saccadic eye movements in schizophrenia","volume":"26","author":"Larrison","year":"2011","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib527","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/aje\/kwi123","article-title":"Risk factors for autism: perinatal factors, parental psychiatric history, and socioeconomic status","volume":"161","author":"Larsson","year":"2005","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib528","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/jmg.2004.029439","article-title":"Mutations in PHF are associated with X linked mental retardation and cleft lip\/cleft palate","volume":"42","author":"Laumonnier","year":"2005","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib529","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.neubiorev.2008.09.006","article-title":"Gene-environment interaction during early development in the heterozygous reeler mouse: clues for modeling of major neurobehavioral syndromes","volume":"33","author":"Laviola","year":"2009","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib530","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrg2719","article-title":"Establishing, maintaining and modifying DNA methylation patterns in plants and animals","volume":"11","author":"Law","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib531","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.cell.2010.09.023","article-title":"ATR-X syndrome protein targets tandem repeats and influences allele-specific expression in a size-dependent manner","volume":"143","author":"Law","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib532","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1093\/hmg\/ddr216","article-title":"Reproductive dysfunction and decreased GnRH neurogenesis in a mouse model of CHARGE syndrome","volume":"20","author":"Layman","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib533","unstructured":"Leboyer, M., Tamouza, R., Charron, D., Faucard, R., Perron, H. Human endogenous retrovirus type W (HERV-W) in schizophrenia: a new avenue of research at the gene-environment interface. World J. Biol. Psychiatry, in press."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib534","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1261\/rna.2565011","article-title":"Identification of piRNAs in the central nervous system","volume":"17","author":"Lee","year":"2011","journal-title":"RNA"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib535","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fonc.2012.00021","article-title":"Pathogenic role of the CRL4 ubiquitin ligase in human disease","volume":"2","author":"Lee","year":"2012","journal-title":"Front. Oncol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib536","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.expneurol.2011.10.023","article-title":"The systems biology of neurofibromatosis type 1-critical roles for microRNA","volume":"235","author":"Lee","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib537","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.neubiorev.2011.09.001","article-title":"Genome wide association studies (GWAS) and copy number variation (CNV) studies of the major psychoses: what have we learnt?","volume":"36","author":"Lee","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib538","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/B978-0-444-51892-7.00023-1","article-title":"Fragile X-associated tremor\/ataxia syndrome","volume":"103","author":"Leehey","year":"2012","journal-title":"Handbook Clin. Neurol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib539","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1469-8749.2009.03545.x","article-title":"Neurocognitive outcomes of individuals with a sex chromosome trisomy: XXX, XYY, or XXY: a systematic review","volume":"52","author":"Leggett","year":"2010","journal-title":"Dev. Med. Child. Neurol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib540","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/mrdd.10031","article-title":"The epidemiology of mental retardation: challenges and opportunities in the new millennium","volume":"8","author":"Leonard","year":"2002","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib541","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/sj.mp.4002087","article-title":"Association between the oxytocin receptor (OXTR) gene and autism: relationship to vineland adaptive behavior scales and cognition","volume":"13","author":"Lerer","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib542","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10673220802075852","article-title":"Pharmacological treatment options for autism spectrum disorders in children and adolescents","volume":"16","author":"Leskovec","year":"2008","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib543","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1093\/hmg\/ddp373","article-title":"Imprinting regulates mammalian snoRNA encoding chromatin decondensation and neuronal nucleolar size","volume":"18","author":"Leung","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib544","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.molmed.2010.08.005","article-title":"Potential therapeutic interventions for fragile X syndrome","volume":"16","author":"Levenga","year":"2010","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib545","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.bbagrm.2008.01.001","article-title":"The role of reelin in adult synaptic function and the genetic and epigenetic regulation of the reelin gene","volume":"1779","author":"Levenson","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib546","doi-asserted-by":"crossref","first-page":"15763","DOI":"10.1074\/jbc.M511767200","article-title":"Evidence that DNA (cytosine-5) methyltransferase regulates synaptic plasticity in the hippocampus","volume":"281","author":"Levenson","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib547","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.tins.2011.10.004","article-title":"Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia","volume":"35","author":"Lewis","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib548","doi-asserted-by":"crossref","first-page":"14075","DOI":"10.1073\/pnas.1008850107","article-title":"Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres","volume":"107","author":"Lewis","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib549","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1101\/gad.1886410","article-title":"Jarid2 and PRC2, partners in regulating gene expression","volume":"24","author":"Li","year":"2010","journal-title":"Genet. Dev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib550","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.gde.2011.01.022","article-title":"Chromatin higher-order structures and gene regulation","volume":"21","author":"Li","year":"2011","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib551","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1021\/ci2002445","article-title":"Identification of inhibitors against p90 ribosomal S6 kinase 2 (RSK2) through structure-based virtual screening with the inhibitor-constrained refined homology model","volume":"51","author":"Li","year":"2011","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib552","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.cub.2005.09.043","article-title":"The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1","volume":"15","author":"Li","year":"2005","journal-title":"Curr. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib553","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2009.01.058","article-title":"A\u00a0microRNA imparts robustness against environmental fluctuation during development","volume":"137","author":"Li","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib554","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1124\/jpet.111.185660","article-title":"CTEP: a novel, potent, long-acting, and orally bioavailable metabotropic glutamate receptor 5 inhibitor","volume":"339","author":"Lindermann","year":"2011","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib555","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nature10214","article-title":"A\u00a0role for glia in the progression of Rett's syndrome","volume":"475","author":"Lioy","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib556","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrn3192","article-title":"Mechanisms of CaMKII action in long-term potentiation","volume":"13","author":"Lisman","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib557","doi-asserted-by":"crossref","first-page":"18398","DOI":"10.1073\/pnas.1013106107","article-title":"Structural basis for recognition of arginine methylated Piwi proteins by the extended Tudor domain","volume":"107","author":"Liu","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib558","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1073\/pnas.1110368109","article-title":"Sperm-borne microRNA-34c is required for the first cleavage division in mouse","volume":"109","author":"Liu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib559","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1042\/BST20110737","article-title":"Histone transfer among chaperones","volume":"40","author":"Liu","year":"2012","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib560","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1128\/MCB.25.7.2819-2831.2005","article-title":"Characterization of E3 Histone, a novel testis ubiquitin protein ligase which ubiquitinates histones","volume":"25","author":"Liu","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib561","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S1097-2765(00)80257-9","article-title":"Phosphorylation of serine 10 in histone H3 is functionally linked in\u00a0vitro and in\u00a0vivo to Gcn5-mediated acetylation at lysine 14","volume":"5","author":"Lo","year":"2000","journal-title":"Mol. Cell."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib562","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/hmg\/ddp480","article-title":"PHF8, a gene associated with cleft lip\/palate and mental retardation, encodes for an N-epsilon-dimethyl lysine demethylase","volume":"19","author":"Loenarz","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib563","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2165\/11587790-000000000-00000","article-title":"Role of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention","volume":"25","author":"Logrip","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib564","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1016\/j.bmc.2011.01.046","article-title":"Inhibitors of histone demethylases","volume":"19","author":"Lohse","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib565","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1042\/BSR20100124","article-title":"Brain-derived MeCP2 complex supports a role for MeCP2 in RNA processing","volume":"31","author":"Long","year":"2011","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib566","unstructured":"Loomis, E.W., Eid, J.S., Peluso, P., Yin, J., Hickey, L., Rank, D., McCalmon, S., Hagerman, R.J., Tassone, E., Hagerman, P.J. Sequencing the unsequenceable: expanded CGG-repeat alleles of the fragile X gene. Genome Res., in press."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib567","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/jmedgenet-2011-100354","article-title":"Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein\u2013Taybi syndrome","volume":"49","author":"Lopez-Atalaya","year":"2012","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib568","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","article-title":"Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy","volume":"16","author":"Loscher","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib569","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1371\/journal.pone.0001158","article-title":"Induced prion protein controls immune-activated retroviruses in the mouse spleen","volume":"2","author":"Lotscher","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib570","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1098\/rstb.2006.1883","article-title":"Axon pruning: an essential step underlying the developmental plasticity of neuronal connections","volume":"361","author":"Low","year":"2006","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib571","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.nlm.2011.03.001","article-title":"Epigenetic gene regulation in the adult mammalian brain: multiple roles in memory formation","volume":"96","author":"Lubin","year":"2011","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib572","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.brainresbull.2010.10.009","article-title":"Novel insights into CaMKII function and regulation during memory formation","volume":"85","author":"Lucchesi","year":"2011","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib573","doi-asserted-by":"crossref","first-page":"16952","DOI":"10.1073\/pnas.1002653107","article-title":"Role for the nuclear receptor-binding SET domain protein 1 (NSD1) methyltransferase in coordinating lysine 36 methylation at histone 3 with RNA polymerase II function","volume":"107","author":"Lucio-Eterovic","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib574","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/MCO.0b013e32833192bc","article-title":"Folic acid fortification: a double-edged sword","volume":"12","author":"Lucock","year":"2009","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib575","first-page":"140","article-title":"Insights into the pathogenesis of XXY phenotype from comparison of the clinical syndrome with an experimental XXY mouse model","volume":"8","author":"Lue","year":"2010","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib576","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ejhg.2008.208","article-title":"Structural variation in Xq28; MECP2 duplications in 1% of patients with unexplained XLMR and in 2% of patients with severe encephalopathy","volume":"17","author":"Lugtenberg","year":"2009","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib577","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-publhealth-031210-101230","article-title":"Prenatal famine and adult health","volume":"32","author":"Lumey","year":"2011","journal-title":"Annu. Rev. Public Health"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib578","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/jcbfm.2009.253","article-title":"Ischaemic preconditioning regulates expression of microRNAs and a predicted target, MeCP2, in mouse cortex","volume":"30","author":"Lusardi","year":"2009","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib579","doi-asserted-by":"crossref","first-page":"7929","DOI":"10.1128\/MCB.00617-06","article-title":"Role of topoisomerase HB in the expression of developmentally regulated genes","volume":"26","author":"Lyu","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib580","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1126\/science.1166859","article-title":"Neuronal activity-induced Gadd45b promotes epigenetic DNA demethylation and adult neurogenesis","volume":"323","author":"Ma","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib581","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/nn.2672","article-title":"Epigenetic choreographers of neurogenesis in the adult mammalian brain","volume":"13","author":"Ma","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib582","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.tins.2011.04.001","article-title":"Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes","volume":"34","author":"Mabb","year":"2011","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib583","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1523\/JNEUROSCI.5966-09.2010","article-title":"Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate","volume":"30","author":"Maezawa","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib584","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1523\/JNEUROSCI.0324-09.2009","article-title":"Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions","volume":"29","author":"Maezawa","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib585","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/hmg\/ddi097","article-title":"MeCP2 deficiency in Rett syndrome causes epigenetic aberrations at the PWS\/AS imprinting center that affects UBE3A expression","volume":"14","author":"Makedonski","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1083","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1093\/hmg\/dds106","article-title":"DISC1 variants 37W and 607F disrupt its nuclear targeting and regulatory role in ATF4-mediated transcription","volume":"21","author":"Malavasi","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib586","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.cell.2012.02.039","article-title":"CNVs: harbingers of a rare variant revolution in psychiatric genetics","author":"Malhotra","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib587","unstructured":"Malina, A., Mills, J.R., Pelletier, J. Emerging therapeutics targeting mRNA translation. Hot Summer Airport Retrosp. Biol., in press."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib588","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/emboj\/21.3.202","article-title":"Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration","volume":"21","author":"Mallucci","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib589","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/npp.2011.21","article-title":"Selective \u03b14\u03b22 nicotinic acetylcholine receptor agonists target epigenetic mechanisms in cortical GABAergic neurons","volume":"36","author":"Maloku","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib590","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cell.2009.01.045","article-title":"Small RNAs as guardians of the genome","volume":"136","author":"Malone","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib591","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.cell.2010.10.016","article-title":"A\u00a0model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells","volume":"143","author":"Marchetto","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib592","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1749-6632.2011.06216.x","article-title":"Advancing drug discovery for schizophrenia","volume":"1236","author":"Marder","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib593","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mrfmmm.2006.07.012","article-title":"The Chd family of chromatin remodelers","volume":"618","author":"Marfella","year":"2007","journal-title":"Mutat. Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib594","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2010.09.038","article-title":"EphB-mediated degradation of the RhoA GEF Ephexin5 relieves a developmental brake on excitatory synapse formation","volume":"143","author":"Margolis","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib595","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/hmg\/ddi198","article-title":"CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome","volume":"14","author":"Mari","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib596","doi-asserted-by":"crossref","first-page":"12770","DOI":"10.1073\/pnas.1202944109","article-title":"Modeling human cortical development in\u00a0vitro using induced pluripotent stem cells","volume":"109","author":"Mariani","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib597","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nrn3155","article-title":"Interneuron dysfunction in psychiatric disorders","volume":"13","author":"Marin","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib598","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00213-010-2035-0","article-title":"Prenatal stress: role in psychotic and depressive diseases","volume":"214","author":"Markham","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib599","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/j.1471-4159.2008.05703.x","article-title":"Dopaminergic system dysregulation in the mrsk2 KO mouse, an animal model of the Coffin\u2013Lowry syndrome","volume":"107","author":"Marques-Pereira","year":"2008","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib600","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00439-007-0424-1","article-title":"The first large duplication of the RSK2 gene identified in a Coffin\u2013Lowry syndrome patient","volume":"1222","author":"Marques Pereira","year":"2007","journal-title":"Hum. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib601","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/ajmg.b.30530","article-title":"Cytogenetic and molecular characterization of A2BP1\/FOX1 as a candidate gene for autism","volume":"144B","author":"Martin","year":"2007","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib602","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.schres.2011.09.020","article-title":"A\u00a0systematic meta-review grading the evidence for non-genetic risk factors and putative antecedents of schizophrenia","volume":"133","author":"Matheson","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib603","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1124\/mol.110.070896","article-title":"Activation of group II metabotropic glutamate receptors promotes DNA demethylation in the mouse brain","volume":"80","author":"Matrisciano","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib604","first-page":"929","article-title":"Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice","volume":"37","author":"Matrisciano","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib605","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/npp.2011.274","article-title":"Pharmacological activation of group-II metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in mice","volume":"37","author":"Matrisciano","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib606","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.ridd.2009.06.003","article-title":"Intellectual disability and its relationship to autism spectrum disorders","volume":"30","author":"Matson","year":"2009","journal-title":"Res. Dev. Disabil."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib607","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.mehy.2006.05.015","article-title":"Molecular mechanism based on self-replicating protein conformation for the inheritance of acquired information in humans","volume":"67","author":"Maury","year":"2006","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib608","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/bies.201100071","article-title":"Human pluripotent stem cells for disease modelling and drug screening","volume":"34","author":"Maury","year":"2012","journal-title":"Bioessays"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib609","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1126\/science.1179438","article-title":"Essential role of the histone methyltransferase G9a in cocaine-induced plasticity","volume":"327","author":"Maze","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0b013e3182060469","article-title":"Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome\/velocardiofacial syndrome)","volume":"90","author":"McDonald-McGinn","year":"2011","journal-title":"Medicine"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib611","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.conb.2012.03.009","article-title":"Astrocytes conspire with neurons during progression of neurological disease","volume":"22","author":"McGann","year":"2012","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib612","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nn.2270","article-title":"Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse","volume":"12","author":"McGowan","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib613","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/schbul\/sbq101","article-title":"Developmental vitamin D deficiency and risk of schizophrenia: a 10-year update","volume":"36","author":"McGrath","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib614","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2174\/138920211795677886","article-title":"Fragile X syndrome","volume":"12","author":"McLennan","year":"2011","journal-title":"Curr. Genomics"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib615","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1037\/0735-7044.122.2.293","article-title":"Evidence for social anxiety and impaired social cognition in a mouse model of fragile X syndrome","volume":"122","author":"McNaughton","year":"2008","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib616","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/B978-0-444-52002-9.00023-1","article-title":"Autism and related disorders","volume":"106","author":"McPartland","year":"2012","journal-title":"Handbook Clin. Neurol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib617","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.nlm.2011.04.005","article-title":"HDAC3 and the molecular brake pad hypothesis","volume":"96","author":"McQuown","year":"2011","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib618","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/nn1110-1313","article-title":"Epigenetic regulation of the neural transcriptome: the meaning of the marks","volume":"13","author":"Meaney","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib619","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/hmg\/ddn424","article-title":"Altered visual function and interneuron survival in Atrx knockout mice: inference for the human syndrome","volume":"18","author":"Medina","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib620","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/emmm.201201410","article-title":"5\u2013HT6 receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia","volume":"4","author":"Meffre","year":"2012","journal-title":"EMBO J. Mol. Med."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib621","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.pneurobio.2008.10.001","article-title":"Epigenetic principles and mechanisms underlying nervous system functions in health and disease","volume":"86","author":"Mehler","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib622","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00439-010-0918-0","article-title":"Transcriptome profile reveals AMPA receptor dysfunction in the hippocampus of the Rsk2-knockout mice, an animal model of Coffin\u2013Lowry","volume":"129","author":"Mehmood","year":"2011","journal-title":"Hum. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib623","doi-asserted-by":"crossref","first-page":"e26077","DOI":"10.1371\/journal.pone.0026077","article-title":"mGluR5-antagonist mediated reversal of elevated stereotyped, repetitive behaviors in the VPA model of autism","volume":"6","author":"Mehta","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib624","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.biopsych.2008.11.019","article-title":"Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia","volume":"65","author":"Mellios","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib625","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyt.2012.00039","article-title":"The emerging role of microRNAs in schizophrenia and autism spectrum disorders","volume":"3","author":"Mellios","year":"2012","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1084","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1093\/hmg\/dds130","article-title":"Ube3a-ATS is an atypical RNA polymerase II transcript that represses the paternal expression of Ube3a","volume":"21","author":"Meng","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib626","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/jmg.2009.067884","article-title":"Novel foxgl mutations associated with the congenital variant of Rett syndrome","volume":"47","author":"Mencarelli","year":"2009","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib627","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/ajmg.b.30934","article-title":"Regionally reduced brain volume, altered serotonin neurochemistry and abnormal behavior in mice null for the circadian rhythm output gene magel2","volume":"150B","author":"Mercer","year":"2009","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib628","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1073\/pnas.0706729105","article-title":"Specific expression of long noncoding RNAs in the mouse brain","volume":"105","author":"Mercer","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib629","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2202-11-14","article-title":"Long noncoding RNAs in neuronal-glial fate specification and oligodendrocyte lineage maturation","volume":"11","author":"Mercer","year":"2010","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib630","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.tig.2009.10.006","article-title":"Copy number variants in neurodevelopmental disorders: promises and challenges","volume":"25","author":"Merikangas","year":"2009","journal-title":"Trends Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib631","doi-asserted-by":"crossref","first-page":"6350","DOI":"10.1093\/nar\/gkq463","article-title":"PARP1 ADP ribosylates lysine residues of the core histone tails","volume":"38","author":"Messner","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib632","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1093\/nar\/gkq931","article-title":"The Bowen-Conradi syndrome protein Nep1 (Emg1) has a dual role in eukaryotic ribosome biogenesis, as an essential assembly factor and in the methylation of \u03c81191 in yeast 18S","volume":"39","author":"Meyer","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib633","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.pneurobio.2009.10.018","article-title":"Epidemiology-driven neurodevelopmental animal models of schizophrenia","volume":"90","author":"Meyer","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib634","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuron.2012.03.009","article-title":"Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice","volume":"74","author":"Michalon","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib635","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00335-012-9416-0","article-title":"Generation of the Sotos syndrome deletion in mice","volume":"23","author":"Migdalska","year":"2012","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib636","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/GIM.0b013e3181ff67ba","article-title":"Autism spectrum disorders \u2013 a genetics review","volume":"13","author":"Miles","year":"2011","journal-title":"Genet. Med."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib637","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1469-7610.2008.01909.x","article-title":"Pre- and peri-natal environmental risks for attention-deficit hyperactivity disorder (ADHD): the potential role of epigenetic processes in mediating susceptibility","volume":"49","author":"Mill","year":"2008","journal-title":"J.\u00a0Child. Psychol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib638","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.ajhg.2008.01.008","article-title":"Epigenomic profiling reveals DNA-methylation changes associated with major psychosis","volume":"82","author":"Mill","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib639","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.coph.2011.01.008","article-title":"MicroRNA in the regulation and expression of serotonergic transmission in the brain and other tissues","volume":"11","author":"Millan","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib640","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pharmthera.2005.11.006","article-title":"Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application","volume":"110","author":"Millan","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib641","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00213-005-2199-1","article-title":"N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives","volume":"179","author":"Millan","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib642","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2515\/therapie:2005065","article-title":"Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies","volume":"60","author":"Millan","year":"2005","journal-title":"Therapie"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib643","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrd3628","article-title":"Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy","volume":"11","author":"Millan","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib644","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.tips.2008.06.007","article-title":"Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions","volume":"29","author":"Millan","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib645","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.brainres.2010.03.035","article-title":"MicroRNA dysregulation in psychiatric disease","volume":"1338","author":"Miller","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib646","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1073\/pnas.1113793109","article-title":"MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function","volume":"109","author":"Miller","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib647","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.nlm.2007.07.016","article-title":"DNA methylation and histone acetylation work in concert to regulate memory formation and synaptic plasticity","volume":"89","author":"Miller","year":"2008","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib648","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nn.2560","article-title":"Cortical DNA methylation maintains remote memory","volume":"13","author":"Miller","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib649","doi-asserted-by":"crossref","first-page":"e9706","DOI":"10.1371\/journal.pone.0009706","article-title":"GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism","volume":"5","author":"Mines","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib650","doi-asserted-by":"crossref","first-page":"e18422","DOI":"10.1371\/journal.pone.0018422","article-title":"Prion protein expression regulates embryonic stem cell pluripotency and differentiation","volume":"6","author":"Miranda","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib651","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1074\/jbc.M111.315291","article-title":"Makorin ring zinc finger protein 1 (MKRN1), a novel poly(A)-binding protein-interacting protein, stimulates translation in nerve cells","volume":"287","author":"Miroci","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib652","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1471-4159.2005.03040.x","article-title":"Histone deacetylase inhibitors decrease reelin promoter methylation in\u00a0vitro","volume":"93","author":"Mitchell","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib653","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.conb.2010.08.009","article-title":"The genetics of neurodevelopmental disease","volume":"21","author":"Mitchell","year":"2011","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib654","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1006\/nbdi.2001.0463","article-title":"Neurobehavioral and electroencephalographic abnormalities in Ube3a maternal-deficient mice","volume":"9","author":"Miura","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib655","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-1-4614-0653-2_7","article-title":"Epigenetics in autism and other neurodevelopmental diseases","volume":"724","author":"Miyake","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib656","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.neuron.2012.04.025","article-title":"Dynamic FoxG1 expression coordinates the integration of multipolar pyramidal neuron precursors into the cortical plate","volume":"74","author":"Miyoshi","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib657","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jmb.2011.04.050","article-title":"ICF syndrome mutations cause a broad spectrum of biochemical defects in DNMT3B-mediated de novo DNA methylation","volume":"409","author":"Moarefi","year":"2011","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib658","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nbt.2158","article-title":"Inhibition of natural antisense transcripts in\u00a0vivo results in gene-specific transcriptional upregulation","volume":"30","author":"Modarresi","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib659","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1242\/dev.048181","article-title":"Kcnq1ot1 noncoding RNA mediates transcriptional gene silencing by interacting with Dnmt1","volume":"137","author":"Mohammad","year":"2010","journal-title":"Development"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib660","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4161\/epi.4.5.9242","article-title":"Epigenetics of imprinted long noncoding RNAs","volume":"4","author":"Mohammad","year":"2009","journal-title":"Epigenetics"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib661","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/YPG.0b013e32832cebd2","article-title":"Aberrations in folate metabolic pathway and altered susceptibility to autism","volume":"19","author":"Mohammad","year":"2009","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib662","article-title":"DNA methylation and its basic function","author":"Moore","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib663","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.nbd.2010.04.004","article-title":"Mice with altered serotonin 2C receptor RNA editing display characteristics of Prader\u2013Willi syndrome","volume":"39","author":"Morabito","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib664","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature11058","article-title":"Sustained translational repression by elF2\u03b1-P mediates prion neurodegeneration","volume":"485","author":"Moreno","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib665","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ajhg.2010.10.004","article-title":"Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia","volume":"87","author":"Moreno-De-Luca","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib666","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1007\/s10803-007-0492-z","article-title":"Brief report: autistic symptoms, developmental regression, mental retardation, epilepsy, and dyskinesias in CNS folate deficiency","volume":"38","author":"Moretti","year":"2008","journal-title":"J.\u00a0Autism Dev. Disord."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib667","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.brainres.2012.03.036","article-title":"Abnormal microglial-neuronal spatial organization in the dorsolateral prefrontal cortex in autism","volume":"1456","author":"Morgan","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib668","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1111\/j.1460-9568.2011.07884.x","article-title":"Molecular mechanisms of maternal cannabis and cigarette use on human neurodevelopment","volume":"34","author":"Morris","year":"2011","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib669","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/wrna.79","article-title":"RNA nucleotide methylation","volume":"2","author":"Motorin","year":"2011","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib670","doi-asserted-by":"crossref","first-page":"11748","DOI":"10.1523\/JNEUROSCI.1887-11.2011","article-title":"Early prenatal stress epigenetically programs dysmasculinization in second-generation offspring via the paternal lineage","volume":"31","author":"Morgan","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib671","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.siny.2012.07.008","article-title":"MicroRNAs and neuronal development","volume":"17","author":"Motti","year":"2012","journal-title":"Semin. Fetal Neonatal Med."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib672","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1523\/JNEUROSCI.0937-07.2007","article-title":"Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of Fragile X syndrome","volume":"16","author":"Muddashetty","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib673","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.molcel.2011.05.006","article-title":"Reversible inhibition of PSD-95 mRNA translation by miR-125a, FMRP phosphorylation, and mGluR signaling","volume":"42","author":"Muddashetty","year":"2011","journal-title":"Mol. Cell."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib674","doi-asserted-by":"crossref","first-page":"R159","DOI":"10.1093\/hmg\/ddm196","article-title":"The necessary junk: new functions for transposable elements","volume":"16","author":"Muotri","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib675","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature09544","article-title":"L1 retrotransposition in neurons is modulated by MeCP2","volume":"468","author":"Muotri","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib676","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/hipo.20564","article-title":"Environmental influence on L1 retrotransposons in the adult hippocampus","volume":"19","author":"Muotri","year":"2009","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib677","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/nn.2436","article-title":"Dynamic DNA methylation programs persistent adverse effects of early-life stress","volume":"12","author":"Murgatroyd","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib678","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyt.2011.00016","article-title":"Epigenetics of early child development","volume":"2","author":"Murgatroyd","year":"2011","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib679","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1093\/hmg\/9.20.3101","article-title":"Disruption of the mouse Necdin gene results in hypothalamic and behavioral alterations reminiscent of the human Prader\u2013Willi syndrome","volume":"9","author":"Muscatelli","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib680","doi-asserted-by":"crossref","first-page":"9061","DOI":"10.1093\/nar\/gkr613","article-title":"Handpicking epigenetic marks with PHD fingers","volume":"39","author":"Musselman","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib681","doi-asserted-by":"crossref","DOI":"10.1038\/nchembio.1042","article-title":"AID\/APOBEC deaminases disfavor modified cytosines implicated in DNA demethylation","author":"Nabel","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib682","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1126\/science.1163802","article-title":"The air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin","volume":"322","author":"Nagano","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib683","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4161\/epi.1.4.3514","article-title":"Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation","volume":"1","author":"Nagarajan","year":"2006","journal-title":"Epigenetics"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib684","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/aur.24","article-title":"MECP2 promoter methylation and X chromosome inactivation in autism","volume":"1","author":"Nagarajan","year":"2008","journal-title":"Autism Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib685","first-page":"1155","article-title":"In silico prediction of novel inhibitors of the DNA binding activity of FoxG1","volume":"8","author":"Nair","year":"2012","journal-title":"Med. Chem."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib686","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.molcel.2011.05.033","article-title":"X-linked mental retardation gene CUL4B targets ubiquitylation of H3K4 methyltransferase component WDR5 and regulates neuronal gene expression","volume":"43","author":"Nakagawa","year":"2011","journal-title":"Mol. Cell."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib687","doi-asserted-by":"crossref","first-page":"15537","DOI":"10.1073\/pnas.0707484104","article-title":"Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors","volume":"104","author":"Nakamoto","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib688","doi-asserted-by":"crossref","first-page":"15873","DOI":"10.1073\/pnas.0903413106","article-title":"DISC1 splice variants are upregulated in schizophrenia and associated with risk polymorphisms","volume":"106","author":"Nakata","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib689","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.cell.2009.04.024","article-title":"Abnormal behavior in a chromosome-engineered mouse model for human 15q11\u201313 duplication seen in autism","volume":"137","author":"Nakatai","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib690","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1073\/pnas.0608056104","article-title":"Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation","volume":"4104","author":"Nan","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib691","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.cell.2008.07.031","article-title":"The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP","volume":"134","author":"Napoloi","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib692","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1476-5381.2009.00526.x","article-title":"Pharmacology of epigenetics in brain disorders","volume":"159","author":"Narayan","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib693","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.coph.2011.06.008","article-title":"Studying synaptic plasticity in the human brain and opportunities for drug discovery","volume":"11","author":"Nathan","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib694","first-page":"607","article-title":"The future therapeutic potential of histone demethylases: a critical analysis","volume":"12","author":"Natoli","year":"2009","journal-title":"Curr. Opin. Drug Discov. Dev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib695","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/jnr.23001","article-title":"Altered microtubule dynamics in Mecp2-deficient astrocytes","volume":"90","author":"Nectoux","year":"2012","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib696","first-page":"1288","article-title":"The major histocompatibility complex and autism spectrum disorder","volume":"72","author":"Needleman","year":"2012","journal-title":"Dev. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib697","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/ana.22124","article-title":"Rett syndrome: revised diagnostic criteria and nomenclature","volume":"68","author":"Neul","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib698","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.molcel.2009.07.027","article-title":"A\u00a0method for genetically installing site-specific acetylation in recombinant histones defines the effects of H3 K56 acetylation","volume":"36","author":"Neumann","year":"2009","journal-title":"Mol. Cell."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib699","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1096\/fj.10-154484","article-title":"Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA, whose protein product is reduced in autistic brain","volume":"24","author":"Nguyen","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib700","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.tcb.2012.01.002","article-title":"Active DNA demethylation by Gadd45 and DNA repair","volume":"22","author":"Niehrs","year":"2012","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib701","doi-asserted-by":"crossref","first-page":"5924","DOI":"10.1523\/JNEUROSCI.4650-11.2012","article-title":"Evidence for a fragile X mental retardation protein-mediated translational switch in metabotropic glutamate receptor-triggered Arc translation and long-term depression","volume":"25","author":"Niere","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib702","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nature08909","article-title":"Expansion of the eukaryotic proteome by alternative splicing","volume":"463","author":"Nilsen","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib703","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1073\/pnas.0409648102","article-title":"DNA methyltransferase 1 regulates reelin mRNA expression in mouse primary cortical cultures","volume":"102","author":"Noh","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib704","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.jpsychires.2011.06.013","article-title":"DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder","volume":"45","author":"Nohesara","year":"2011","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib705","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1093\/hmg\/ddn011","article-title":"MeCP2-dependent repression of an imprinted miR-184 released by depolarisation","volume":"17","author":"Nomura","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib706","doi-asserted-by":"crossref","first-page":"6465","DOI":"10.1093\/nar\/gkr304","article-title":"Phosphorylation of histone H3(T118) alters nucleosome dynamics and remodeling","volume":"39","author":"North","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib707","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1196\/annals.1316.013","article-title":"Psychostimulant alters expression of DNA methyltransferase mRNA in the rat brain","volume":"1025","author":"Numachi","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib708","first-page":"112","article-title":"A\u00a0seizure-prone phenotype is associated with altered free-running rhythm in Pten mutant mice","volume":"1168","author":"Ogawa","year":"2007","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib709","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1093\/schbul\/sbn105","article-title":"Environmental studies of schizophrenia through the prism of epigenetics","volume":"34","author":"Oh","year":"2008","journal-title":"Schizophr. Bull."},{"issue":"4","key":"10.1016\/j.neuropharm.2012.11.015_bib710","doi-asserted-by":"crossref","first-page":"e35354","DOI":"10.1371\/journal.pone.0035354","article-title":"Alterations of gene expression and glutamate clearance in astrocytes derived from a MeCP2-null mouse model of Rett syndrome","volume":"7","author":"Okabe","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib711","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1002\/ajmg.a.31771","article-title":"22q13 microduplication in two patients with common clinical manifestations: a recognizable syndrome?","volume":"143a","author":"Okamoto","year":"2007","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib712","doi-asserted-by":"crossref","first-page":"26562","DOI":"10.1074\/jbc.M605391200","article-title":"PCAF modulates PTEN activity","volume":"281","author":"Okumura","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib713","doi-asserted-by":"crossref","first-page":"9929","DOI":"10.1523\/JNEUROSCI.1714-10.2010","article-title":"Defective GABAergic neurotransmission and pharmacological rescue of neuronal hyperexcitability in the amygdala in a mouse model of fragile X syndrome","volume":"30","author":"Olmos-Serrano","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib714","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/hmg\/ddm022","article-title":"Trisomy for the Down syndrome critical region is necessary but not sufficient for brain phenotypes of trisomic mice","volume":"16","author":"Olson","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib715","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nrg2100","article-title":"Chromatin crosstalk in development and disease: lessons from REST","volume":"8","author":"Ooi","year":"2007","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib716","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.reprotox.2009.02.014","article-title":"Valproic acid in pregnancy: how much are we endangering the embryo and fetus?","volume":"28","author":"Ornoy","year":"2009","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib717","doi-asserted-by":"crossref","first-page":"15616","DOI":"10.1523\/JNEUROSCI.3888-10.2010","article-title":"Hypersensitivity to mGluR5 and ERK1\/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome","volume":"30","author":"Osterweil","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib718","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejmg.2012.01.004","article-title":"A\u00a0novel c.2T>C mutation of the KDM5C\/JARID1C gene in one large family with X-linked intellectual disability","volume":"55","author":"Ounap","year":"2012","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib719","doi-asserted-by":"crossref","first-page":"e19955","DOI":"10.1371\/journal.pone.0019955","article-title":"The genetic variation of RELN expression in schizophrenia and bipolar disorder","volume":"6","author":"Ovadia","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib720","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0002-9440(10)62964-1","article-title":"Developmental abnormalities of neuronal structure and function in prenatal mice lacking the Prader\u2013Willi syndrome gene necdin","volume":"167","author":"Pagliardini","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib721","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1365-2990.2012.01292.x","article-title":"The neuropathological consequences of CDKL5 mutation","volume":"38","author":"Paine","year":"2012","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib722","doi-asserted-by":"crossref","first-page":"e27878","DOI":"10.1371\/journal.pone.0027878","article-title":"MiR-135A regulates preimplantation embryo development through down-regulation of E3 ubiquitin ligase Seven in Absentia Homolog 1A (SIAH1A) expression","volume":"6","author":"Pang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1085","doi-asserted-by":"crossref","first-page":"17785","DOI":"10.1073\/pnas.1004361107","article-title":"Disrupted-in-schizophrenia 1 (DISC1) plays essential roles in mitochondria in collaboration with Mitofilin","volume":"107","author":"Park","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib723","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.neuropharm.2011.04.025","article-title":"Mouse models of genetic effects on cognition: relevance to schizophrenia","volume":"62","author":"Papaleo","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib724","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1749-6632.2009.04978.x","article-title":"Risk factors for development of depression and psychosis. Glucocorticoid receptors and pituitary implications for treatment with antidepressant and glucocorticoids","volume":"1179","author":"Pariante","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib725","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1111\/j.1582-4934.2008.00463.x","article-title":"One carbon metabolism disturbances and the C677T MTHFR gene polymorphism in children with autism spectrum disorders","volume":"13","author":"Pasca","year":"2009","journal-title":"J.\u00a0Cell. Mol. Med."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib726","doi-asserted-by":"crossref","first-page":"e46773","DOI":"10.1371\/journal.pone.0046773","article-title":"Neurofibromin 1 is a miRNA target in neurons","volume":"7","author":"Paschou","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib727","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/humu.21424","article-title":"NSD1 PHD domains bind methylated H3K4 and H3K9 using interactions disrupted by point mutations in human Sotos syndrome","volume":"32","author":"Pasillas","year":"2011","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib728","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/mrdd.20162","article-title":"Genetic mechanisms involved in the phenotype of Down syndrome","volume":"13","author":"Patterson","year":"2007","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib729","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00439-009-0696-8","article-title":"Molecular genetic analysis of Down syndrome","volume":"126","author":"Patterson","year":"2009","journal-title":"Hum. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib730","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrg1525","article-title":"Down syndrome and genetics \u2013 a case of linked histories","volume":"6","author":"Patterson","year":"2005","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib731","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbr.2008.12.016","article-title":"Immune involvement in schizophrenia and autism: etiology, pathology and animal models","volume":"204","author":"Patterson","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib732","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nature09965","article-title":"Shank3 mutant mice display autistic-like behaviours and striatal dysfunction","volume":"472","author":"Peca","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib733","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ajmg.b.30386","article-title":"Positive association of schizophrenia to JARID2 gene","volume":"144B","author":"Pedrosa","year":"2007","journal-title":"Am. J. Med. Genet. B. Neuropsychiatr. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib734","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/01677063.2011.597908","article-title":"Development of patient-specific neurons in schizophrenia using induced pluripotent stem cells","volume":"25","author":"Pedrosa","year":"2011","journal-title":"J.\u00a0Neurogenet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib735","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000335287","article-title":"Pitt-Hopkins syndrome","volume":"2","author":"Peippo","year":"2012","journal-title":"Mol. Syndromol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib736","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1146\/annurev.genom.8.080706.092249","article-title":"The pathophysiology of Fragile X syndrome","volume":"8","author":"Penagarikano","year":"2007","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib737","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/ijms11010222","article-title":"ERK in learning and memory: a review of recent research","volume":"11","author":"Peng","year":"2010","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib738","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/ejhg.2009.189","article-title":"Coffin\u2013Lowry syndrome","volume":"18","author":"Pereira","year":"2010","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib739","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/npp.2009.188","article-title":"Valproate and amitriptyline exert common and divergent influences on global and gene promoter-specific chromatin modifications in rat primary astrocytes","volume":"35","author":"Perisic","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib740","first-page":"369","article-title":"Protein components of the microRNA pathway and human diseases","volume":"487","author":"Perron","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib741","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.molmed.2011.02.003","article-title":"Balancing histone methylation activities in psychiatric disorders","volume":"17","author":"Peter","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib742","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00335-008-9139-4","article-title":"Imprinted noncoding RNAs","volume":"19","author":"Peters","year":"2008","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib743","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.tig.2012.02.005","article-title":"Overcoming the nucleosome barrier during transcript elongation","volume":"28","author":"Petesch","year":"2012","journal-title":"Trends Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib744","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nature09230","article-title":"Epigenetics as a unifying principle in the aetiology of complex traits and disease","volume":"465","author":"Petronis","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib745","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000334260","article-title":"The 22q13.3 deletion syndrome (Phelan-McDermid syndrome)","volume":"2","author":"Phelan","year":"2012","journal-title":"Mol. Syndromol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib746","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/clpt.2012.82","article-title":"Gene, stem cell, and future therapies for orphan diseases","volume":"92","author":"Philipps","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib747","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11689-010-9066-z","article-title":"Angelman syndrome: advancing the research frontier of neurodevelopmental disorders","volume":"3","author":"Philpot","year":"2011","journal-title":"J.\u00a0Neurodev. Disord."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib748","article-title":"Alterations of GABAergic signaling in autism spectrum disorders","volume":"2012","author":"Pizzarelli","year":"2011","journal-title":"Neural Plast."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib750","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10519-006-9116-1","article-title":"Deletion of the Coffin\u2013Lowry syndrome gene Rsk2 in mice is associated with impaired spatial learning and reduced control of exploratory behavior","volume":"37","author":"Poirier","year":"2007","journal-title":"Behav. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib751","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.gde.2007.08.008","article-title":"Functional organization of the genome during interphase","volume":"17","author":"Pombo","year":"2007","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib752","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000334064","article-title":"Disentangling the myriad genomics of complex disorders, specifically focusing on autism, epilepsy, and schizophrenia","volume":"135","author":"Poot","year":"2011","journal-title":"Cytogenet. Genome Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib753","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.2007.0030-1299.16435.x","article-title":"Epigenetic effects of infection on the phenotype of host offspring: parasites reaching across host generation","volume":"117","author":"Poulin","year":"2008","journal-title":"Oikos"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib754","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/nrn2513","article-title":"Why do many psychiatric disorders emerge during adolescence?","volume":"9","author":"Pous","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib755","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jhevol.2012.04.008","article-title":"Social organization and the evolution of cumulative technology in apes and hominins","volume":"63","author":"Pradhan","year":"2012","journal-title":"J.\u00a0Hum. Evol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib756","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nrd3649","article-title":"Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap","volume":"11","author":"Pratt","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1086","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.gene.2012.08.040","article-title":"A peculiar mutation in the DNA-binding\/dimerization domain of NFIX causes Sotos-like overgrowth syndrome: a new case","volume":"511","author":"Priolo","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib757","doi-asserted-by":"crossref","first-page":"25","DOI":"10.31887\/DCNS.2010.12.1\/cptak","article-title":"Epigenetic approaches to psychiatric disorders","volume":"12","author":"Ptak","year":"2010","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib758","doi-asserted-by":"crossref","first-page":"R233","DOI":"10.1016\/j.cub.2007.02.030","article-title":"On the use of the word \u201cepigenetic\u201d","volume":"17","author":"Ptashne","year":"2007","journal-title":"Curr. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib759","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1586\/ern.09.142","article-title":"Progressive structural brain changes in schizophrenia","volume":"10","author":"Puri","year":"2010","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib760","doi-asserted-by":"crossref","first-page":"386","DOI":"10.4161\/epi.5.5.12005","article-title":"The paternal hidden agenda: epigenetic inheritance through sperm chromatin","volume":"5","author":"Puri","year":"2010","journal-title":"Epigenetics"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib761","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s11920-010-0102-1","article-title":"Small RNA-mediated gene regulation in neurodevelopmental disorders","volume":"12","author":"Qurashi","year":"2010","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib762","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.brainres.2010.03.110","article-title":"Long non-coding RNAs in nervous system function and disease","volume":"1338","author":"Qureshi","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib763","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neulet.2009.07.093","article-title":"Regulation of non-coding RNA networks in the nervous system \u2013 what's the REST of the story?","volume":"466","author":"Qureshi","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib764","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nature09261","article-title":"Histone H4K20\/H3K9 demethylase PHF8 regulates zebrafish brain and craniofacial development","volume":"466","author":"Qi","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib765","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2006.04.057","article-title":"Doppel: more rival than double to prion","volume":"141","author":"Qin","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib766","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/cr.2010.81","article-title":"The X-linked mental retardation gene PHF8 is a histone demethylase involved in neuronal differentiation","volume":"20","author":"Qiu","year":"2010","journal-title":"Cell. Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib767","doi-asserted-by":"crossref","first-page":"7403","DOI":"10.1073\/pnas.1116661109","article-title":"Mechanisms of activation of the paternally expressed genes by the Prader\u2013Willi imprinting center in the Prader\/Willi\/Angelman syndromes domains","volume":"109","author":"Rabinovitz","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib768","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bandc.2012.02.006","article-title":"Training the brain: fact and fad in cognitive and behavioral remediation","volume":"79","author":"Rabipour","year":"2012","journal-title":"Brain Cogn."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib769","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.neures.2007.08.007","article-title":"Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms","volume":"59","author":"Rachidi","year":"2007","journal-title":"Neurosci. Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2012.11.015_bib770","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2174\/138161210790170166","article-title":"Treating the cognitive deficits of schizophrenia with alpha4beta2 neuronal nicotinic receptor agonists","volume":"16","author":"Radek","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib771","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.nbd.2011.03.021","article-title":"A\u00a0pulse rapamycin therapy for infantile spasms and associated cognitive decline","volume":"43","author":"Raffo","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib772","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1089\/hum.2011.087","article-title":"Zinc-finger nucleases for somatic gene therapy: the next frontier","volume":"22","author":"Rahman","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib773","first-page":"6693","article-title":"A\u00a0role for neuronal piRNAs in the epigenetic control of memory-related synaptic plasticity","volume":"149","author":"Rajesethuspathy","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib774","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.neuron.2009.05.029","article-title":"Characterization of small RNAs in Aplysia reveals a role for miR-124 in constraining synaptic plasticity through CREB","volume":"63","author":"Rajasethypathy","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib775","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.gde.2012.02.013","article-title":"Combinatorial complexity in chromatin structure and function: revisiting the histone code","volume":"22","author":"Rando","year":"2012","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib776","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.tins.2009.01.007","article-title":"Decision by division: making cortical maps","volume":"32","author":"Rakic","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib777","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/ajmg.a.33184","article-title":"The MECP2 duplication syndrome","volume":"152A","author":"Ramocki","year":"2010","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib778","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev.biochem.78.071107.134639","article-title":"Genome-wide views of chromatin structure","volume":"78","author":"Rando","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib779","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/sj.mp.4001642","article-title":"The neurodevelopmental model of schizophrenia: update 2005","volume":"10","author":"Rapoport","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib780","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/CHI.0b013e31818b1c63","article-title":"Autism spectrum disorders and childhood-onset schizophrenia: clinical and biological contributions to a relation revisited","volume":"48","author":"Rapoport","year":"2009","journal-title":"J.\u00a0Am. Child. Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib781","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/mp.2012.23","article-title":"Neurodevelopmental model of schizophrenia: update 2012","volume":"17","author":"Rapoport","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib782","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature04674","article-title":"RNA-mediated non-Mendelian inheritance of an epigenetic change in the mouse","volume":"441","author":"Rassoulzadegan","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib783","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1002\/ajmg.a.31416","article-title":"Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation","volume":"140","author":"Rauch","year":"2006","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib784","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1093\/emboj\/cdg288","article-title":"NSD1 is essential for early post-implantation development and has a catalytically active SET domain","volume":"12","author":"Rayasam","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib785","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nature05918","article-title":"Stability and flexibility of epigenetic gene regulation in mammalian development","volume":"447","author":"Reik","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib786","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1093\/hmg\/ddl225","article-title":"Expression of the Rho-GEF Pbl\/ECT2 is regulated by the Ube3 E3 ubiquitin ligase","volume":"15","author":"Reiter","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib787","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1460-9568.2009.07048.x","article-title":"Behavioural and cognitive abnormalities in an imprinting centre deletion mouse model for Prader\u2013Willi syndrome","volume":"31","author":"Relkovic","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib788","unstructured":"Relkovic, D., Isles, A.R. Behavioural and cognitive profiles of mouse models for Prader\u2013Willi syndrome. Brain Res. Bull., in press."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib789","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.neuroscience.2009.09.005","article-title":"Cellular prion protein modulates age related behavioral and neurochemical alterations in mice","volume":"104","author":"Rial","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib790","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/hmg\/ddq563","article-title":"Reduced AKT\/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model","volume":"20","author":"Ricciardi","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib791","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrg1834","article-title":"Inherited epigenetic variation: revisiting soft inheritance","volume":"7","author":"Richards","year":"2006","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib792","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/gad.1735809","article-title":"Making synaptic plasticity and memory last: mechanisms of translational regulation","volume":"23","author":"Richter","year":"2009","journal-title":"Genes Dev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib793","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4161\/epi.19507","article-title":"Epigenetic reprogramming of cancer cells via targeted DNA methylation","volume":"7","author":"Rivenbark","year":"2012","journal-title":"Epigenetics"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib794","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbrc.2011.06.077","article-title":"The presence of 5-hydroxymethylcytosine at the gene promoter and not in the gene body negatively regulates gene expression","volume":"411","author":"Robertson","year":"2011","journal-title":"Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib795","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1469-7610.2011.02380.x","article-title":"Annual research review: transgenic mouse models of childhood-onset psychiatric disorders","volume":"52","author":"Robertson","year":"2011","journal-title":"J.\u00a0Child. Psychol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib796","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1093\/brain\/aws096","article-title":"Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome","volume":"135","author":"Robinson","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib797","doi-asserted-by":"crossref","first-page":"e1182","DOI":"10.1371\/journal.pone.0001182","article-title":"RNA is an integral component of chromatin that contributes to its structural organization","volume":"2","author":"Rodriguez-Campos","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib798","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399407000415","article-title":"Rubinstein\u2013Taybi syndrome: clinical and molecular overview","volume":"9","author":"Roelfsema","year":"2007","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib799","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0140-6736(03)12987-X","article-title":"Down's syndrome","volume":"361","author":"Roizen","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib800","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1042\/BJ20110289","article-title":"Regulation and function of the RSK family of protein kinases","volume":"441","author":"Romeo","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib801","doi-asserted-by":"crossref","first-page":"9342","DOI":"10.1523\/JNEUROSCI.0379-08.2008","article-title":"Histone deacetylase inhibitors decrease cocaine but not sucrose self-administration in rats","volume":"28","author":"Romieu","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib802","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.gde.2008.07.008","article-title":"Genetics of intellectual disability","volume":"18","author":"Ropers","year":"2008","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib803","first-page":"780","article-title":"X-linked mental retardation","volume":"42","author":"Ropers","year":"2005","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib804","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ddrr.85","article-title":"An extra X or Y chromosome: contrasting the cognitive and motor phenotypes in childhood in boys with 47, XYY syndrome or 47, XXY Klinefelter syndrome","volume":"15","author":"Ross","year":"2009","journal-title":"Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib805","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.biopsych.2008.11.028","article-title":"Lasting epigenetic influence of early-life adversity on the BDNF gene","volume":"65","author":"Roth","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib806","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.bbagen.2009.06.009","article-title":"Epigenetic mechanisms in schizophrenia","volume":"1790","author":"Roth","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib807","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ajmg.c.30280","article-title":"Mouse models of cognitive disabilities in trisomy 21 (Down syndrome)","volume":"154C","author":"Roubertoux","year":"2010","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib808","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s10519-006-9052-0","article-title":"Trisomy 21: from chromosomes to mental retardation","volume":"36","author":"Roubertoux","year":"2006","journal-title":"Behav. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib809","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.neuroscience.2010.06.069","article-title":"Behavioral and molecular changes in the mouse in response to prenatal exposure to the anti-epileptic drug valproic acid","volume":"170","author":"Roullet","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib810","doi-asserted-by":"crossref","first-page":"8309","DOI":"10.1073\/pnas.0801273105","article-title":"CTCF physically links cohesin to chromatin","volume":"105","author":"Rubio","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib811","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.yfrne.2007.12.004","article-title":"The EDGE hypothesis: epigenetically directed genetic errors in repeat-containing proteins (RCPs) involved in evolution, neuroendocrine signaling, and cancer","volume":"29","author":"Ruden","year":"2008","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib812","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ejhg.2009.175","article-title":"Identification and characterization of two novel JARIDIC mutations: suggestion of an emerging genotype-phenotype correlation","volume":"18","author":"Rujirabanjerd","year":"2010","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib813","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s12035-012-8314-5","article-title":"The mTOR signaling pathway in the brain: focus on epilepsy and epileptogenesis","volume":"43","author":"Russo","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib814","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/schbul\/sbp104","article-title":"Epigenetic mediation of environmental influences in major psychotic disorders","volume":"35","author":"Rutten","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib815","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.mp.4001954","article-title":"Selective epigenetic alteration of layer 1 GABAergic neurons isolated from prefrontal cortex of schizophrenia patients using laser-assisted microdissection","volume":"12","author":"Ruzicka","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib816","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1523\/JNEUROSCI.2279-06.2007","article-title":"Impaired cerebellar development and function in mice lacking CAPS2, a protein involved in neurotrophin release","volume":"27","author":"Sadakata","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib817","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.neures.2010.03.006","article-title":"Ca(2+)-dependent activator protein for secretion 2 and autistic-like phenotypes","volume":"67","author":"Sadakata","year":"2010","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib818","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2202-8-25","article-title":"Alternative splicing variation in mouse CAPS2: differential expression and functional properties of splicing variants","volume":"8","author":"Sadakata","year":"2007","journal-title":"BMC Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib819","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1172\/JCI29031","article-title":"Austistic-like phenotypes in Cadps2-knockout mice and aberrant CADPS2 splicing in autistic patients","volume":"117","author":"Sadakata","year":"2007","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib820","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/400_005","article-title":"Mechanisms for nucleosome movement by ATP-dependent chromatin remodeling complexes","volume":"41","author":"Saha","year":"2006","journal-title":"Results Probl. Cell. Differ."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib821","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/hmg\/ddi045","article-title":"Epigenetic overlap in autism-spectrum neurodevelopmental disorders. MECP2 deficiency causes reduced expression of UBE3A and GABRB3","volume":"14","author":"Samaco","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib822","doi-asserted-by":"crossref","first-page":"21966","DOI":"10.1073\/pnas.0912257106","article-title":"Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioural abnormalities","volume":"106","author":"Samaco","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib823","doi-asserted-by":"crossref","first-page":"7951","DOI":"10.1523\/JNEUROSCI.0169-11.2011","article-title":"Complexities of Rett syndrome and MeCP2","volume":"31","author":"Samaco","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib824","first-page":"364","article-title":"The PHD finger: a versatile epigenome reader","volume":"36","author":"Sanchez","year":"2011","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib825","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/B978-0-444-54299-1.00004-2","article-title":"Aberrant epigenetic landscape in intellectual disability","volume":"197","author":"Sanchez-Mut","year":"2012","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib826","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fpsyt.2010.00153","article-title":"The HDAC inhibitor phenylbutyrate reverses effects of neonatal ventral hippocampal lesion in rats","volume":"1","author":"Sandner","year":"2011","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib827","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/sj.ejhg.5201778","article-title":"CHARGE syndrome: an update","volume":"4","author":"Sanlaville","year":"2007","journal-title":"Eur. J. Hum."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib828","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.biopsych.2010.09.030","article-title":"Upregulation of dicer and microRNA expression in the dorsolateral prefrontal cortex Brodmann area 46 in schizophrenia","volume":"69","author":"Santarelli","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib829","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2011.04.065","article-title":"A\u00a0novel nonsense mutation in KDM5C\/JARID1C gene causing intellectual disability, short stature and speech delay","volume":"498","author":"Santos-Rebou\u00e7as","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib830","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/gm144","article-title":"Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell lines","volume":"2","author":"Sarachana","year":"2010","journal-title":"Genome Med."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib831","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/jmedgenet-2011-100225","article-title":"Association between deletion size and important phenotypes expands the genomic region of interest in Phelan\u2013McDermid syndrome (22q13) deletion syndrome)","volume":"48","author":"Sarasyan","year":"2011","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib832","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/j.1742-4658.2011.08089.x","article-title":"MicroRNAs and epigenetics","volume":"278","author":"Sato","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib833","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.1073\/pnas.1001281107","article-title":"Genomic imprinting of experience-dependent cortical plasticity by the ubiquitin ligase gene Ube3a","volume":"107","author":"Sato","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib834","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0959-4388(02)00322-7","article-title":"Molecular mechanisms controlling cortical gliogenesis","volume":"12","author":"Sauvageot","year":"2002","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib835","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.neuron.2009.11.019","article-title":"Control of cognition and adaptive behavior by the GLP\/G9a epigenetic suppressor complex","volume":"64","author":"Schaefer","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib836","first-page":"125","article-title":"Epigenetic mechanisms of mental retardation","volume":"67","author":"Schaefer","year":"2011","journal-title":"Prog. Drug Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib837","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1093\/hmg\/ddq424","article-title":"A\u00a0single postnatal injection of oxytocin rescues the lethal feeding behaviour in mouse newborns deficient for the imprinted Magel2 gene","volume":"19","author":"Schaller","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib838","doi-asserted-by":"crossref","first-page":"R138","DOI":"10.1093\/hmg\/ddl213","article-title":"Epigenetics of autism spectrum disorders","volume":"15","author":"Schanen","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib839","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/yea.2898","article-title":"Genetic interactions of yeast NEP1 (EMG1), encoding an essential factor in ribosome biogenesis","volume":"29","author":"Schilling","year":"2012","journal-title":"Yeast"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib840","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ddrr.80","article-title":"Fragile X syndrome - from genes to cognition","volume":"15","author":"Schneider","year":"2009","journal-title":"Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib841","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1471-4159.2011.07423.x","article-title":"Altered ERK\/MAPK signaling in the hippocampus of the mrsk2 KO mouse model of Coffin\u2013Lowry syndrome","volume":"119","author":"Schneider","year":"2011","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib842","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrg1981","article-title":"Polycomb silencing mechanisms and the management of genomic programmes","volume":"8","author":"Schwartz","year":"2007","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib843","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004028.pub3","article-title":"Valproate for schizophrenia","author":"Schwarz","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib844","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1749-8104-6-11","article-title":"Monoalelic deletion of the microRNA biogenesis gene Dgcr8 produces deficits in the development of excitatory synaptic transmission in the prefrontal cortex","volume":"6","author":"Schofield","year":"2011","journal-title":"Neural Dev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib845","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.biochi.2011.05.026","article-title":"From snoRNA to miRNA: dual function regulatory non-coding RNAs","volume":"93","author":"Scott","year":"2011","journal-title":"Biochimie"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib846","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrg2591","article-title":"From DNA sequence to transcriptional behavior: a quantitative approach","volume":"10","author":"Segal","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib847","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.bbagrm.2010.08.012","article-title":"Tuning acetylation levels with HAT activators: therapeutic strategy in neurodegenerative diseases","volume":"1799","author":"Selvi","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib848","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.tig.2010.08.007","article-title":"The piRNA pathway: a fly's perspective on the guardian of the genome","volume":"26","author":"Senti","year":"2010","journal-title":"Trends Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib849","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1095\/biolreprod.105.047829","article-title":"Spatio-developmental distribution of the prion-like protein doppel in mammalian testis: a comparative analysis focusing on its presence in the acrosome of spermatids","volume":"74","author":"Serres","year":"2006","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib850","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10519-010-9440-3","article-title":"Conservation of structural and functional elements of TSC1 and TSC2: a bioinformatic comparison across animal models","volume":"41","author":"Serfontein","year":"2011","journal-title":"Behav. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib851","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0896-6273(02)00768-7","article-title":"Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3","volume":"35","author":"Shahbazian","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib852","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1523\/JNEUROSCI.3696-09.2010","article-title":"Dysregulation of mTOR signaling in fragile X syndrome","volume":"30","author":"Sharma","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib853","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.schres.2007.09.020","article-title":"Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: analysis of the national brain databank microarray collection","volume":"98","author":"Sharma","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib854","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/carcin\/bgp220","article-title":"Epigenetics in cancer","volume":"31","author":"Sharma","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib855","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.biopsych.2012.04.023","article-title":"Altered development of the dorsolateral prefrontal cortex in chromosome 22q11.2 deletion syndrome: an in\u00a0vivo proton spectroscopy study","volume":"72","author":"Shashi","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib856","doi-asserted-by":"crossref","first-page":"e26203","DOI":"10.1371\/journal.pone.0026203","article-title":"Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome","volume":"6","author":"Sheridan","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib857","doi-asserted-by":"crossref","first-page":"13141","DOI":"10.1073\/pnas.1004829107","article-title":"Neurofibromin regulates corticostriatal inhibitory networks during working memory performance","volume":"107","author":"Shilyansky","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib858","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1101\/gad.2027411","article-title":"H3K9 methltransferase G9a and the related molecule GLP","volume":"25","author":"Shinkai","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib859","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1073\/pnas.1012220108","article-title":"Calcium-dependent activator protein for secretion 2 (CAPS2) promotes BDNF secretion and is critical for the development of GABAergic interneuron network","volume":"108","author":"Shinoda","year":"2011","journal-title":"Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib860","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1073\/pnas.1012311108","article-title":"DNA methyltransferase 1, cytosine methylation, and cytosine hydroxymethylation in mammalian mitochondria","volume":"108","author":"Shock","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib861","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1158\/0008-5472.CAN-07-6487","article-title":"A\u00a0new pharmacologic action of CCI-779 involves FKBP12-independent inhibition of mTOR kinase activity and profound repression of global protein synthesis","volume":"68","author":"Shor","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib862","first-page":"E1","article-title":"Epigenetic signatures of autism","volume":"7","author":"Shulha","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib863","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/j.1471-4159.2006.03971.x","article-title":"Altered signaling pathways underlying abnormal hippocampal synaptic plasticity in the Ts65Dn mouse model of Down syndrome","volume":"98","author":"Siarye","year":"2006","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib864","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.gde.2011.04.008","article-title":"MicroRNAs in neurons: manifold regulatory roles at the synapse","volume":"21","author":"Siegel","year":"2011","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib865","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1210\/jc.2012-1182","article-title":"Beneficial effects of growth hormone treatment on cognition in children with Prader\u2013Willi syndrome: a randomized controlled trial and longitudinal study","volume":"97","author":"Siemensma","year":"2012","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib866","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nature08855","article-title":"Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia","volume":"464","author":"Sigurdsson","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib867","doi-asserted-by":"crossref","first-page":"124548","DOI":"10.1155\/2012\/124548","article-title":"Matrix metalloproteinases and minocycline: therapeutic avenues for fragile X syndrome","volume":"2012","author":"Siller","year":"2012","journal-title":"Neural Plast."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib868","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.tibs.2007.11.003","article-title":"Intriguing nucleic acid-binding features of mammalian prion protein","volume":"33","author":"Silva","year":"2008","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib869","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1073\/pnas.0510341103","article-title":"The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases","volume":"103","author":"Simonini","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib870","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2174\/156800911795655930","article-title":"Post-translational modifications of PTEN and their potential therapeutic implications","volume":"11","author":"Singh","year":"2011","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib871","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4161\/epi.6.2.13589","article-title":"Histone tyrosine phosphorylation comes of age","volume":"6","author":"Singh","year":"2010","journal-title":"Epigenetics"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib872","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/ncb1903","article-title":"Histone levels are regulated by phosphorylation and ubiquitylation-dependent proteolysis","volume":"11","author":"Singh","year":"2009","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib873","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.2741\/3441","article-title":"Generation and management of excess histones during the cell cycle","volume":"14","author":"Singh","year":"2009","journal-title":"Front. Biosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib874","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.nbd.2011.03.011","article-title":"MeCP2 is required for global heterochromatic and nucleolar changes during activity-dependent neuronal maturation","volume":"43","author":"Singleton","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib875","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nsmb.1391","article-title":"MicroRNAs control de novo DNA methylation through regulation of transcriptional repressors in mouse embryonic stem cells","volume":"15","author":"Sinkkonen","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib876","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nrm3089","article-title":"PIWI-interacting small RNAs: the vanguard of genome defence","volume":"12","author":"Siomi","year":"2011","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib877","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.molcel.2010.01.030","article-title":"Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state","volume":"37","author":"Skene","year":"2010","journal-title":"Mol. Cell."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib878","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1534\/genetics.109.102798","article-title":"Epigenetic inheritance and the missing heritability problem","volume":"182","author":"Slatkin","year":"2009","journal-title":"Genetics"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib879","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tig.2011.09.004","article-title":"De novo DNA methylation: a germ cell perspective","volume":"28","author":"Smallwood","year":"2012","journal-title":"Trends Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib880","doi-asserted-by":"crossref","first-page":"16910","DOI":"10.1523\/JNEUROSCI.3660-10.2010","article-title":"Fragile X protein FMRP is required for homeostatic plasticity and regulation of synaptic strength by retinoic acid","volume":"30","author":"Soden","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib881","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1212\/WNL.0b013e3182166dc7","article-title":"Autism, Alzheimer disease, and fragile X","volume":"76","author":"Sokol","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib882","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrm3330","article-title":"The functions and regulation of the PTEN tumour suppressor","volume":"13","author":"Song","year":"2012","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib883","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1017\/S0033291707002504","article-title":"The phenomenology and diagnosis of psychiatric illness in people with Prader\u2013Willi syndrome","volume":"38","author":"Soni","year":"2008","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib884","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.neubiorev.2008.05.007","article-title":"Stress and glucocorticoid footprints in the brain \u2013 the path from depression to Alzheimer's disease","volume":"32","author":"Sotiropoulos","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib885","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tibs.2010.11.001","article-title":"Prion hypothesis: the end of the controversy?","volume":"36","author":"Soto","year":"2011","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib886","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/cmdc.201000158","article-title":"New anacardic acid-inspired benzamides: histone lysine acetyltransferase activators","volume":"5","author":"Souto","year":"2010","journal-title":"Chem. Med. Chem."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib888","doi-asserted-by":"crossref","unstructured":"Spadaro, P.A., Bredy, T.W. Emerging roles of non-coding RNA in neural plasticity, cognitive function, and neuropsychiatric disorders. Front. Genet. 3, 1\u201315, in press.","DOI":"10.3389\/fgene.2012.00132"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1087","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.tips.2012.09.004","article-title":"Synapse dysfunction in autism: a molecular medicine approach to drug discovery in neurodevelopmental disorders","volume":"33","author":"Spooren","year":"2012","journal-title":"Trends Pharmacol Sci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib889","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.siny.2011.04.011","article-title":"Mitochondrial DNA mutations and depletion in pediatric medicine","volume":"16","author":"Spinazzola","year":"2011","journal-title":"Semin. Fetal Neonatal Med."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib890","doi-asserted-by":"crossref","first-page":"5940","DOI":"10.1038\/sj.onc.1205762","article-title":"The DNA repair protein, O(6)-methylguanine-DNA methyltransferase is a proteolytic target for the E6 human papillomavirus oncoprotein","volume":"21","author":"Srivenugopal","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib891","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/humupd\/dmq002","article-title":"Mitochondrial DNA transmission, replication and inheritance: a journey from the gamete through the embryo and into offspring and embryonic stem cells","volume":"16","author":"St John","year":"2010","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib892","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ng.138","article-title":"Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model","volume":"40","author":"Stark","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib893","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/nn.2924","article-title":"The conundrums of understanding genetic risks for autism spectrum disorders","volume":"14","author":"State","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib894","doi-asserted-by":"crossref","first-page":"e7845","DOI":"10.1371\/journal.pone.0007845","article-title":"Periconceptional maternal folic acid use of 400 microg per day is related to increased methylation of the IGF2 gene in the very young child","volume":"4","author":"Steegers-Theunissen","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib895","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrm2347","article-title":"Small non-coding RNAs in animal development","volume":"9","author":"Stefani","year":"2008","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib896","doi-asserted-by":"crossref","first-page":"9447","DOI":"10.1073\/pnas.0903964106","article-title":"Modulation of long-term memory for object recognition via HDAC inhibition","volume":"106","author":"Stefanko","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib897","series-title":"GeneReviews\u2122 [Internet]","article-title":"Rubinstein\u2013Taybi syndrome","author":"Stevens","year":"2002"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib898","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ajmg.c.30148","article-title":"The chromosome 9q subtelomere deletion syndrome","volume":"145C","author":"Stewart","year":"2007","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib899","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/nature06994","article-title":"A\u00a0phosphatase cascade by which rewarding stimuli control nucleosomal response","volume":"453","author":"Stipanovich","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib900","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1073\/pnas.0730775100","article-title":"Epigenetic abnormalities associated with a chromosome 18(q21-q22) inversion and a Gilles de la Tourette syndrome phenotype","volume":"100","author":"State","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib901","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/ncb1663","article-title":"Ring1-mediated ubiquitination of H2A restrains poised RNA polymerase II at bivalent genes in mouse ES cells","volume":"9","author":"Stock","year":"2007","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib902","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/bfgp\/els018","article-title":"Proteins involved in establishment and maintenance of imprinted methylation marks","volume":"11","author":"Stroganstsev","year":"2012","journal-title":"Brief. Funct. Genomics"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib903","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ejcb.2010.11.015","article-title":"Cellular prion protein localizes to the nucleus of endocrine and neuronal cells and interacts with structural chromatin components","volume":"90","author":"Strom","year":"2011","journal-title":"Eur. J. Cell. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib904","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00213-010-2130-2","article-title":"Early continuous inhibition of group 1 mGlu signaling partially rescues dendritic spine abnormalities in the Fmr1 knockout mouse model for fragile X syndrome","volume":"215","author":"Su","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib905","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/path.2633","article-title":"Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours","volume":"220","author":"Subramanian","year":"2010","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib906","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nature07456","article-title":"Neuroligins and neurexins link synaptic function to cognitive disease","volume":"455","author":"S\u00fcdhof","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib907","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.nlm.2012.03.007","article-title":"Epigenetic regulation of reelin and brain-derived neurotrophic factor genes in long-term potentiation in rat medial prefrontal cortex","volume":"97","author":"Sui","year":"2012","journal-title":"J.\u00a0Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib908","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/ncomms1532","article-title":"MiR-137 forms a regulatory loop with nuclear receptor TLX and LSD1 in neural stem cells","volume":"2","author":"Sun","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib909","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1460-9568.2011.07607.x","article-title":"Epigenetic regulation of neurogenesis in the adult mammalian brain","volume":"33","author":"Sun","year":"2011","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib910","doi-asserted-by":"crossref","first-page":"8786","DOI":"10.1523\/JNEUROSCI.3257-10.2011","article-title":"Upregulation of CREB-mediated transcription enhances both short- and long-term memory","volume":"31","author":"Suzuki","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib911","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrg2341","article-title":"DNA methylation landscapes: provocative insights from epigenomics","volume":"9","author":"Suzuki","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib912","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2011.05.004","article-title":"Are we studying and treating schizophrenia correctly?","volume":"130","author":"Swerdlow","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib913","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1399-0004.2008.01134.x","article-title":"Noncoding RNAs in mental retardation","volume":"75","author":"Szulwach","year":"2009","journal-title":"Clin. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib914","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1083\/jcb.200908151","article-title":"Cross talk between microRNA and epigenetic regulation in adult neurogenesis","volume":"189","author":"Szulwach","year":"2010","journal-title":"J.\u00a0Cell. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib915","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/nn.2959","article-title":"5-hmc-mediated epigenetic dynamics during postnatal neurodevelopment and aging","volume":"14","author":"Szulwach","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib916","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev-pharmtox-061008-103102","article-title":"Epigenetics, DNA methylation and chromatin modifying drugs","volume":"49","author":"Szyf","year":"2009","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib917","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbagen.2009.01.009","article-title":"The early life environment and the epigenome","volume":"1790","author":"Szyf","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib918","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s11689-011-9079-2","article-title":"DNA methylation, the early-life social environment and behavioral disorders","volume":"3","author":"Szyf","year":"2011","journal-title":"J.\u00a0Neurodev. Disord."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib919","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/sj.ejhg.5201393","article-title":"Differential epigenetic modifications in the FMR1 gene of the fragile X syndrome after reactivating pharmacological treatments","volume":"13","author":"Tabolacci","year":"2005","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib920","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2350-13-13","article-title":"The mGluR5 antagonist AFQ056 does not affect methylation and transcription of the mutant FMR1 gene in\u00a0vitro","volume":"13","author":"Tabolacci","year":"2012","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib921","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1101\/gad.1284005","article-title":"Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9","volume":"19","author":"Tachibana","year":"2005","journal-title":"Genes Dev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib922","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/nature05823","article-title":"The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation","volume":"447","author":"Tahiliani","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib923","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ajhg.2011.09.011","article-title":"Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder","volume":"89","author":"Talkowski","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib924","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2011.08.008","article-title":"Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification","volume":"146","author":"Tan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib925","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1038\/tp.2011.61","article-title":"Disease- and age-related changes in histone acetylation at gene promoters in psychiatric disorders","volume":"1","author":"Tang","year":"2011","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib926","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1086\/511134","article-title":"Mutations in CUL4B, which encodes a ubiquitin E3 ligase subunit, cause an X-linked mental retardation syndrome associated with aggressive outbursts, seizures, relative macrocephaly, central obesity, hypogonadism, pes cavus, and tremor","volume":"80","author":"Tarpey","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib927","series-title":"GeneReviews\u2122 [Internet]","article-title":"Sotos syndrome","author":"Tatton-Brown","year":"1993"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib928","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/sj.ejhg.5201686","article-title":"Sotos syndrome","volume":"15","author":"Tatton-Brown","year":"2007","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib929","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/nsmb1338","article-title":"How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers","volume":"14","author":"Taverna","year":"2007","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib930","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1530\/REP-11-0148","article-title":"Epigenetic reprogramming: is deamination key to active DNA demethylation?","volume":"142","author":"Teperek-Tacz","year":"2011","journal-title":"Reproduction"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib931","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1042\/BST0371126","article-title":"Structure-function studies for the panacea, valproic acid","volume":"37","author":"Terbach","year":"2009","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib932","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-3-642-21649-7_7","article-title":"Molecular and genetic analysis of the Drosophila model of fragile X syndrome","volume":"54","author":"Tessier","year":"2012","journal-title":"Results Probl. Cell. Differ."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib933","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/nature08924","article-title":"CpG islands influence chromatin structure via the CpG-binding protein Cfp1","volume":"464","author":"Thomson","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib934","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1523\/JNEUROSCI.5240-11.2012","article-title":"Foxg1 has an essential role in postnatal development of the dentate gyrus","volume":"32","author":"Tian","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib935","doi-asserted-by":"crossref","first-page":"e34944","DOI":"10.1371\/journal.pone.0034944","article-title":"Otitis media in a new mouse model for CHARGE syndrome with a deletion in the Chd7 gene","volume":"7","author":"Tian","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib936","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1749-6632.2009.05175.x","article-title":"Effects of histone deacetylase inhibitor Trichostatin A on epigenetic changes and transcriptional activation of Bdnf promoter 1 by rat hippocampal neurons","volume":"1199","author":"Tian","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib937","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.gde.2009.04.001","article-title":"The RASopathies: developmental syndromes of Ras\/MAPK pathway dysregulation","volume":"19","author":"Tidyman","year":"2009","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib938","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1093\/hmg\/ddp353","article-title":"DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific","volume":"18","author":"Tobi","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib939","doi-asserted-by":"crossref","first-page":"14374","DOI":"10.1073\/pnas.2336265100","article-title":"The fragile X mental retardation protein is required for type 1 metabotropic glutamate receptor-dependent translation of PSD-95","volume":"100","author":"Todd","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib940","first-page":"1","article-title":"FOXP2 gene and language impairment in schizophrenia: association and epigenetic studies","volume":"114","author":"Tolosa","year":"2010","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib941","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.biopsych.2012.04.026","article-title":"Proenkephalin mediates the enduring effects of adolescent cannabis exposure associated with adult opiate vulnerability","volume":"72","author":"Tomasiewicz","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib942","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/ajmg.a.33484","article-title":"Treatment with valproic acid ameliorates ADHD symptoms in fragile X syndrome boys","volume":"152A","author":"Torrioli","year":"2010","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib943","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.tig.2010.05.007","article-title":"Key role of gene dosage and synaptic homeostasis in autism spectrum disorders","volume":"26","author":"Toro","year":"2010","journal-title":"Trends Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib944","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pnpbp.2012.04.016","article-title":"Valproate induces epigenetic modifications in lympho-monocytes from epileptic patients","volume":"39","author":"Tremolizzo","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib945","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.biopsych.2004.11.046","article-title":"Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice","volume":"57","author":"Tremolizzo","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib946","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.pneurobio.2012.01.005","article-title":"Deregulated mTOR-mediated translation in intellectual disability","volume":"96","author":"Troca-Mar\u00edn","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib947","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.1192002","article-title":"Long noncoding RNA as a modular scaffold of histone modification complexes","volume":"329","author":"Tsai","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib948","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nature11310","article-title":"Autistic-like behavior and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice","volume":"488","author":"Tsai","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib949","unstructured":"Tsai, V., Parker, W.E., Orlova, K.A., Baybis, M., Chi, A.W., Berg, B.D., Bimbaum, J.F., Estevez, J., Okochi, K., Samat, H.B., Flores-Samat, L., Aronica, E., Crino, P.B. Fetal brain mTOR signaling activation in tuberous sclerosis complex. Cereb. Cortex, in press."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib950","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbr.2008.11.039","article-title":"The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia","volume":"204","author":"Tseng","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib951","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/molehr\/gaq019","article-title":"Novel genetic aspects of Klinefelter's syndrome","volume":"16","author":"Tuttelmann","year":"2010","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib952","doi-asserted-by":"crossref","first-page":"e36980","DOI":"10.1371\/journal.pone.0036980","article-title":"Identification of combinatorial patterns of post-translational modifications on individual histones in the mouse brain","volume":"7","author":"Tweedie-Cullen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib953","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/humu.9420","article-title":"Novel JARID1C\/SMCX mutations in patients with X-linked mental retardation","volume":"27","author":"Tzschach","year":"2006","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib954","unstructured":"Uchino, S., Waga, C. Shank3 as an autism spectrum disorder-associated gene. Brain Dev., in press."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib955","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1242\/dev.02293","article-title":"Roles for Dnmt3b in mammalian development: a mouse model for the ICF syndrome","volume":"133","author":"Ueda","year":"2006","journal-title":"Development"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib956","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/schbul\/sbr034","article-title":"The development of neural synchrony and large-scale cortical networks during adolescence: relevance for the pathophysiology of schizophrenia and neurodevelopmental hypothesis","volume":"37","author":"Uhlhaas","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib957","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jmb.2011.12.036","article-title":"An analog of BIX-01294 selectively inhibits a family of histone H3 lysine 9 jumonji demethylases","volume":"416","author":"Upadhyay","year":"2012","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib958","doi-asserted-by":"crossref","first-page":"656","DOI":"10.4161\/epi.5.7.13055","article-title":"Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome","volume":"5","author":"Urdinguio","year":"2010","journal-title":"Epigenetics"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib959","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S1474-4422(09)70262-5","article-title":"Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies","volume":"8","author":"Urdinguio","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib960","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.neuropharm.2011.02.021","article-title":"Induced pluripotent stem cells: a new tool to confront the challenge of neuropsychiatric disorders","volume":"60","author":"Vacarino","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib961","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.conb.2009.12.003","article-title":"Neuronal migration mechanisms in development and disease","volume":"20","author":"Valiente","year":"2010","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib962","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1523\/JNEUROSCI.4737-10.2011","article-title":"Ablation of CBP in forebrain principal neurons causes modest memory and transcriptional defects and a dramatic reduction of histone acetylation but does not affect cell viability","volume":"31","author":"Valor","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib963","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000330755","article-title":"Analysis of FOXG1 is highly recommended in male and female patients with Rett syndrome","volume":"1","author":"Van der Aa","year":"2011","journal-title":"Mol. Syndromol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1088","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000329580","article-title":"MECP2 Duplication Syndrome","volume":"2","author":"Van Esch","year":"2012","journal-title":"Mol Syndromol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib964","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nbd.2010.03.010","article-title":"Disruption of the epigenetic code: an emerging mechanism in mental retardation","volume":"39","author":"Van Bokhoven","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib965","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1086\/444549","article-title":"Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males","volume":"77","author":"Van Esch","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib966","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nature09563","article-title":"The environment and schizophrenia","volume":"468","author":"Van Os","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib967","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.tics.2012.04.004","article-title":"Explaining brain size variation: from social to cultural brain","volume":"16","author":"Van Schaik","year":"2012","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib968","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nn1845","article-title":"Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of alphaCaMKII inhibitory phosphorylation","volume":"10","author":"Van Woerden","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib969","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nature06268","article-title":"SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation","volume":"450","author":"Vaquero","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib970","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.1523\/JNEUROSCI.0296-07.2007","article-title":"Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB: CBP-dependent transcriptional activation","volume":"27","author":"Vecsler","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib971","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4161\/epi.5.1.10630","article-title":"MeCP2 deficiency downregulates specific nuclear proteins that could be partially recovered by valproic acid in\u00a0vitro","volume":"5","author":"Vecsler","year":"2010","journal-title":"Epigenetics"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1089","doi-asserted-by":"crossref","first-page":"e20733","DOI":"10.1371\/journal.pone.0020733","article-title":"Ex vivo treatment with a novel synthetic aminoglycoside NB54 in primary fibroblasts from Rett syndrome patients suppresses MECP2 nonsense mutations","volume":"6","author":"Vecsler","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib972","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/npp.2011.185","article-title":"Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments","volume":"37","author":"Veenstra-VanderWeele","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib973","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1073\/pnas.2637013100","article-title":"DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains","volume":"101","author":"Veldic","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib974","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrg3241","article-title":"De novo mutations in human genetic disease","volume":"13","author":"Veltman","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib975","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1352\/2008.113:342-355","article-title":"Strategies and correlates of Jigsaw puzzle and visuospatial performance by persons with Prader\u2013Willi syndrome","volume":"113","author":"Verdine","year":"2008","journal-title":"Am. J. Ment. Retard."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib976","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000260045","article-title":"Psychiatric profile in Rubinstein\u2013Taybi syndrome. A review and case report","volume":"43","author":"Verhoeven","year":"2010","journal-title":"Psychopathology"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib977","doi-asserted-by":"crossref","first-page":"34839","DOI":"10.1074\/jbc.M111.258384","article-title":"Importance of Shank3 protein in regulating metabotropic glutamate receptor 5 (mGluR5) expression and signaling at synapses","volume":"286","author":"Verpelli","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib978","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/1471-2164-12-229","article-title":"Meta-analysis of heterogenous Down syndrome data reveals consistent genome-wide dosage effects related to neurological processes","volume":"12","author":"Vilardell","year":"2011","journal-title":"BMC Genomics"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib979","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1601-183X.2011.00763.x","article-title":"The effect of an mGluR5 inhibitor on procedural memory and avoidance discrimination impairments in Fmr1 KO mice","volume":"11","author":"Vinueza Veloz","year":"2012","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib980","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/ng1407","article-title":"Mutations in a new member of the chromodomain gene family cause CHARGE syndrome","volume":"36","author":"Vissers","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib982","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1242\/jcs.054957","article-title":"Long nuclear-retained non-coding RNAs and allele-specific higher-order chromatin organization at imprinted snoRNA gene arrays","volume":"123","author":"Vitali","year":"2010","journal-title":"J.\u00a0Cell. Sci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib983","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.conb.2010.04.002","article-title":"MicroRNA pathways in neural development and plasticity","volume":"20","author":"Vo","year":"2010","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib984","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature10110","article-title":"Transcriptomic analysis of autistic brain reveals convergent molecular pathology","volume":"474","author":"Voineagu","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib985","doi-asserted-by":"crossref","first-page":"e20982","DOI":"10.1371\/journal.pone.0020982","article-title":"Neurexin-1 and frontal lobe white matter: an overlapping intermediate phenotype for schizophrenia and autism spectrum disorders","volume":"6","author":"Voineskos","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib986","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/biot.201100021","article-title":"The various facets of the protein-folding activity of the ribosome","volume":"6","author":"Voisset","year":"2011","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib987","first-page":"18","article-title":"The epigenotype","volume":"1","author":"Waddington","year":"1942","journal-title":"Endeavour"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib988","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/1771241a0","article-title":"Embryology, epigenetics and biogenetics","volume":"177","author":"Waddington","year":"1956","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib989","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.devcel.2008.03.009","article-title":"RNA induction and inheritance of epigenetic cardiac hypertrophy in the mouse","volume":"14","author":"Wagner","year":"2008","journal-title":"Dev. Cell."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib990","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1111\/j.1528-1157.1999.tb01583.x","article-title":"Increased sensitivity to seizures in mice lacking cellular prion protein","volume":"40","author":"Walz","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib991","doi-asserted-by":"crossref","first-page":"9065","DOI":"10.1128\/JVI.00961-08","article-title":"Human cytomegalovirus infection alters the expression of cellular microRNA species that affects replication","volume":"82","author":"Wang","year":"2008","journal-title":"J.\u00a0Viral"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib992","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.nurt.2010.05.005","article-title":"Fragile X: leading the way for targeted treatments in autism","volume":"7","author":"Wang","year":"2010","journal-title":"J.\u00a0Am. Soc. Exp. Neurother."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib993","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1093\/hmg\/ddr212","article-title":"Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3","volume":"20","author":"Wang","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib994","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/138920211796429772","article-title":"Shaping the genome with non-coding RNAs","volume":"12","author":"Wang","year":"2011","journal-title":"Curr. Genomics"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib995","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/ar.21232","article-title":"Demethylation of specific Wnt\/\u03b2-catenin pathway genes and its upregulation in rat brain induced by prenatal valproate exposure","volume":"293","author":"Wang","year":"2010","journal-title":"Anat. Rec. (Hoboken)"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib996","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.cell.2009.06.049","article-title":"Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes","volume":"138","author":"Wang","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib997","doi-asserted-by":"crossref","first-page":"523","DOI":"10.4161\/epi.4.8.10155","article-title":"Early environmental effects on epigenetic regulation in humans","volume":"4","author":"Waterland","year":"2009","journal-title":"Epigenetics"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib998","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.conb.2009.03.011","article-title":"Protein translation in synaptic plasticity: mGluR-LTD, Fragile X","volume":"19","author":"Waung","year":"2009","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib999","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1093\/hmg\/dds156","article-title":"The differential effects of prenatal and\/or postnatal rapamycin on neurodevelopmental defects and cognition in a neuroglial mouse model of tuberous sclerosis complex","volume":"21","author":"Way","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1000","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nn1276","article-title":"Epigenetic programming by maternal behavior","volume":"7","author":"Weaver","year":"2004","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1001","doi-asserted-by":"crossref","first-page":"11043","DOI":"10.1523\/JNEUROSCI.3652-05.2005","article-title":"Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life","volume":"25","author":"Weaver","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1002","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1523\/JNEUROSCI.4164-06.2007","article-title":"The transcription factor nerve growth factor-inducible protein A mediates epigenetic programming: altering epigenetic marks by immediate-early genes","volume":"14","author":"Weaver","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1003","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1073\/pnas.0507526103","article-title":"Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood","volume":"103","author":"Weaver","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1004","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/ajmg.a.32212","article-title":"In search of the psychosis gene in people with Prader\u2013Willi syndrome","volume":"A146","author":"Webb","year":"2008","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1005","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1523\/JNEUROSCI.23-07-02634.2003","article-title":"Derangements of hippocampal calcium\/calmodulin-dependent protein kinase II in a mouse model for Angelman mental retardation syndrome","volume":"23","author":"Weeber","year":"2003","journal-title":"J.\u00a0Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2012.11.015_bib1006","article-title":"Inheritable effect of unpredictable maternal separation on behavioral responses in mice","volume":"5","author":"Weiss","year":"2011","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1007","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.cub.2005.09.043","article-title":"The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1","volume":"15","author":"Weiss","year":"2005","journal-title":"Curr. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1008","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1056\/NEJMoa075974","article-title":"Association between microdeletion and microduplication at 16p11.2 and autism","volume":"358","author":"Weiss","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1009","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1093\/hmg\/ddi104","article-title":"Remote control of gene transcription","volume":"14","author":"West","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/128_2011_190","article-title":"The PrP-like proteins Shaddo and doppel","volume":"305","author":"Westaway","year":"2011","journal-title":"Top. Curr. Chem."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1011","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/DBP.0b013e3181ee3833","article-title":"Emerging pharmacotherapies for neurodevelopmental disorders","volume":"31","author":"Wetmore","year":"2010","journal-title":"J.\u00a0Dev. Behav. Pediatr."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1012","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1038\/npp.2012.137","article-title":"Impact of a microRNA MIR137 susceptibility variant on brain function in people at high genetic risk of schizophrenia or bipolar disorder","volume":"37","author":"Whalley","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1013","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/wrna.8","article-title":"The relationship of prions and translation","volume":"1","author":"Wickner","year":"2010","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1014","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/embor.2011.233","article-title":"DNA methylation: TET proteins-guardians of CpG islands?","volume":"13","author":"Williams","year":"2011","journal-title":"EMBO Rep."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1015","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000335648","article-title":"Update on Kleefstra syndrome","volume":"2","author":"Willemsen","year":"2012","journal-title":"Mol. Syndromol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1016","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/ajmg.a.32941","article-title":"A\u00a01q42 deletion involving DISC1, DISC2 and TSNAX in an autism spectrum disorder","volume":"149A","author":"Williams","year":"2009","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1017","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/schbul\/sbr095","article-title":"Molecular mechanisms in 22q11 deletion syndrome","volume":"37","author":"Williams","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1018","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1542\/peds.2007-3204","article-title":"Neurofibromatosis type 1 revisited","volume":"123","author":"Williams","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1019","first-page":"832","article-title":"Genomic imprinting effects on brain development and function","volume":"8","author":"Wilkinson","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1020","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1101\/lm.213906","article-title":"A\u00a0transcription factor-binding domain of the coactivator CBP is essential for long-term memory and the expression of specific target genes","volume":"13","author":"Wood","year":"2006","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1021","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/02643290802685921","article-title":"Task-switching deficits and repetitive behavior in genetic neurodevelopmental disorders: data from children with Prader\u2013Willi syndrome chromosome 15q11-q13 deletion and boys with fragile X syndrome","volume":"26","author":"Woodcock","year":"2009","journal-title":"Cogn. Neuropsychol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1022","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1528-1167.2009.02341.x","article-title":"Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: from tuberous sclerosis to common acquired epilepsies","volume":"51","author":"Wong","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1090","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2741\/3973","article-title":"Histone ubiquitylation and chromatin dynamics","volume":"17","author":"Wright","year":"2012","journal-title":"Front Biosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1023","doi-asserted-by":"crossref","first-page":"18161","DOI":"10.1073\/pnas.1005595107","article-title":"Genome-wide analysis reveals methyl-CpG-binding protein 2-dependent regulation of microRNAs in a mouse model of Rett syndrome","volume":"107","author":"Wu","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1024","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1101\/gad.2036011","article-title":"Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells","volume":"25","author":"Wu","year":"2011","journal-title":"Genet. Dev."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1025","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1126\/science.1190485","article-title":"Dnmt3a-dependent nonpromoter DNA methylation facilitates transcription of neurogenic genes","volume":"329","author":"Wu","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1026","doi-asserted-by":"crossref","first-page":"pe17","DOI":"10.1126\/scisignal.264pe17","article-title":"Reversing DNA methylation: new insights from neuronal activity-induced Gadd45b in adult neurogenesis","volume":"2","author":"Wu","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1027","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/gene.20179","article-title":"Mouse imprinting defect mutations that model Angelman syndrome","volume":"44","author":"Wu","year":"2006","journal-title":"Genesis"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1028","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1471-213X-10-99","article-title":"EMG1 is essential for mouse pre-implantation embryo development","volume":"10","author":"Wu","year":"2010","journal-title":"BMC Dev. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1029","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/nar\/gkp1189","article-title":"The ribosome assembly factor Nep1 responsible for Bowen-Conradi syndrome is a pseudouridine-N1-specific methyltransferase","volume":"38","author":"Wurm","year":"2010","journal-title":"Nucleic Acids Res."},{"issue":"Suppl. 2","key":"10.1016\/j.neuropharm.2012.11.015_bib1030","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1093\/schbul\/sbr064","article-title":"Thinking about the future cognitive remediation therapy -what works and could we do better?","volume":"37","author":"Wykes","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1031","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2217\/epi.10.12","article-title":"Role of H3K4 demethylases in complex neurodevelopmental diseases","volume":"2","author":"Wynder","year":"2010","journal-title":"Epigenomics"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1032","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nature04815","article-title":"A\u00a0PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling","volume":"442","author":"Wysocka","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1033","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nmeth.1903","article-title":"Long-term, efficient inhibition of microRNA function in mice using rAAV vectors","volume":"4","author":"Xie","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1034","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.cell.2011.12.035","article-title":"Base-resolution analyses of sequence and parent-of-origin dependent DNA methylation in the mouse genome","volume":"148","author":"Xie","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1035","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.nbd.2012.02.016","article-title":"MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction","volume":"46","author":"Xu","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1036","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.yhbeh.2010.08.019","article-title":"Reversible histone methylation regulates brain gene expression and behavior","volume":"59","author":"Xu","year":"2011","journal-title":"Horm. Behav."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1037","doi-asserted-by":"crossref","first-page":"11883","DOI":"10.1523\/JNEUROSCI.4114-08.2008","article-title":"The steady-state level of the nervous-system-specific microRNA-124a is regulated by dFMRI in drosophila","volume":"28","author":"Xu","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1038","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1523\/JNEUROSCI.4711-09.2010","article-title":"Dyrk1A overexpression inhibits proliferation and induces premature neuronal differentiation of neural progenitor cells","volume":"30","author":"Yabut","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1039","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3109\/15622975.2011.585663","article-title":"Antidepressant-like effect of sodium butyrate (HDAC inhibitor) and its molecular mechanism of action in the rat hippocampus","volume":"13","author":"Yamawaki","year":"2011","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1040","doi-asserted-by":"crossref","first-page":"6525","DOI":"10.1523\/JNEUROSCI.6107-11.2012","article-title":"Reduced excitatory neurotransmission and mild autism-relevant phenotypes in adolescent Shank3 null mutant mice","volume":"32","author":"Yang","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1041","doi-asserted-by":"crossref","first-page":"8058","DOI":"10.1021\/bi700664y","article-title":"Structural basis for the inhibition of the LSD1 histone demethylase by the antidepressant trans-2-phenylcyclopropylamine","volume":"46","author":"Yang","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1042","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.tips.2010.08.001","article-title":"Targeting DNA methylation for epigenetic therapy","volume":"31","author":"Yang","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1043","doi-asserted-by":"crossref","first-page":"16746","DOI":"10.1021\/ja206312b","article-title":"Selective inhibitors of histone methyltransferase DOT1L: design, synthesis, and crystallographic studies","volume":"133","author":"Yao","year":"2011","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1044","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nn.2327","article-title":"Ube3a is required for experience-dependent maturation of the neocortex","volume":"12","author":"Yashiro","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2040-2392-2-9","article-title":"Gene expression analysis in lymphoblasts derived from patients with autism spectrum disorder","volume":"2","author":"Yasuda","year":"2011","journal-title":"Mol. Autism"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1046","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jneumeth.2010.04.022","article-title":"Experimental identification of microRNA targets on the 3' untranslated region of human FMR1 gene","volume":"190","author":"Yi","year":"2010","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1047","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/jhg.2012.7","article-title":"Missense mutation in the DNA-binding\/dimerization domain of NFIX cause Sotos-like features","volume":"57","author":"Yoneda","year":"2012","journal-title":"J.\u00a0Hum. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1048","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10822-011-9441-1","article-title":"Homology modeling, docking and structure-based pharmacophore of inhibitors of DNA methyltransferase","volume":"25","author":"Yoo","year":"2011","journal-title":"J.\u00a0Comput. Aided. Mol. Des."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1091","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.conb.2009.04.006","article-title":"ATP-dependent chromatin remodeling in neural development","volume":"19","author":"Yoo","year":"2009","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1049","doi-asserted-by":"crossref","first-page":"17551","DOI":"10.1073\/pnas.0507856102","article-title":"Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2","volume":"102","author":"Young","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1050","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev.genom.9.081307.164445","article-title":"Transgenerational epigenetic effects","volume":"9","author":"Youngson","year":"2008","journal-title":"Annu. Rev. Genomics"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1051","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1093\/hmg\/ddq179","article-title":"A\u00a0mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions","volume":"19","author":"Yu","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1052","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/cr.2011.42","article-title":"Readers of histone modifications","volume":"21","author":"Yun","year":"2011","journal-title":"Cell. Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1053","doi-asserted-by":"crossref","first-page":"92R","DOI":"10.1203\/PDR.0b013e318213565e","article-title":"Epigenetic impacts on neurodevelopment: pathophysiologic mechanisms and genetic modes of action","volume":"69","author":"Zahir","year":"2011","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1054","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nn1893","volume":"10","author":"Zalfa","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1055","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.cell.2007.02.016","article-title":"Noncoding RNAs and gene silencing","volume":"128","author":"Zahatiegui","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1056","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0168-9525(01)02446-5","article-title":"A\u00a0high density of X-linked genes for general cognitive ability: a run-away process shaping human evolution?","volume":"17","author":"Zechner","year":"2001","journal-title":"Trends Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1057","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1021\/ja044885g","article-title":"Selective small molecules blocking HIV-1 Tat and coactivator PCAF association","volume":"127","author":"Zeng","year":"2005","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1058","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.21331","article-title":"Rapamycin prevents epilepsy in a mouse model tuberous sclerosis complex","volume":"63","author":"Zeng","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1059","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s10571-010-9578-9","article-title":"The Coffin\u2013Lowry syndrome-associated protein RSK2 and neurosecretion","volume":"30","author":"Zeniou-Meyer","year":"2010","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1060","doi-asserted-by":"crossref","first-page":"13130","DOI":"10.1523\/JNEUROSCI.1039-10.2010","article-title":"Maternal care and DNA methylation of a glutamic acid decarboxylase 1 promoter in rat hippocampus","volume":"30","author":"Zhang","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1061","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.psych.60.110707.163625","article-title":"Epigenetics and the environmental regulation of the genome and its function","volume":"61","author":"Zhang","year":"2010","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1062","doi-asserted-by":"crossref","first-page":"e6977","DOI":"10.1371\/journal.pone.0006977","article-title":"Alternative-splicing in the exon-10 region of GABAA receptor beta(2) subunit gene: relationships between novel isoforms and psychotic disorders","volume":"4","author":"Zhao","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1063","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neuron.2006.09.037","article-title":"Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic, growth, and spine maturation","volume":"52","author":"Zhou","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1064","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1146\/annurev-genet-102108-134205","article-title":"Active DNA demethylation mediated by DNA glycosylases","volume":"43","author":"Zhu","year":"2009","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1065","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.molcel.2005.09.025","article-title":"Monoubiquitination of human histone H2B: the factors involved and their roles in HOX gene regulation","volume":"20","author":"Zhu","year":"2005","journal-title":"Mol. Cell."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1066","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.molcel.2007.07.024","article-title":"A\u00a0histone H2A deubiquitinase complex coordinating histone acetylation and H1 dissociation in transcriptional regulation","volume":"27","author":"Zhu","year":"2007","journal-title":"Mol. Cell."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1067","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.schres.2009.03.020","article-title":"An upregulation of DNA-methyltransferase 1 and 3a expressed in telencephalic GABAergic neurons of schizophrenia patients is also detected in peripheral blood lymphocytes","volume":"111","author":"Zhubi","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1068","unstructured":"Ziats, M.N., Rennert, O.M. Aberrant expression of long noncoding RNAs in autistic brain. J. Mol. Neurosci., in press."},{"issue":"3","key":"10.1016\/j.neuropharm.2012.11.015_bib1069","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009886","article-title":"Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities","volume":"4","author":"Zoghbi","year":"2012","journal-title":"Cold Spring Harb Perspect. Biol."},{"key":"10.1016\/j.neuropharm.2012.11.015_bib1070","doi-asserted-by":"crossref","first-page":"7913","DOI":"10.1128\/MCB.01220-06","article-title":"Negative and positive regulation of gene expression by mouse histone deacetylase 1","volume":"26","author":"Zupkovitz","year":"2006","journal-title":"Mol. Cell. Biol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081200562X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081200562X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T04:20:14Z","timestamp":1714710014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839081200562X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":1085,"alternative-id":["S002839081200562X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.11.015","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}